{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "pd.options.display.max_colwidth = 300\n",
    "pd.options.display.max_columns = 300\n",
    "import numpy as np\n",
    "from pathlib import Path\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "DATA_DIR=Path(\"../data\")\n",
    "nm2mol = 1E9"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>comp_molregno</th>\n",
       "      <th>act_standard_units</th>\n",
       "      <th>act_standard_type</th>\n",
       "      <th>act_activity_comment</th>\n",
       "      <th>act_bao_endpoint</th>\n",
       "      <th>act_type</th>\n",
       "      <th>ass_assay_id</th>\n",
       "      <th>ass_description</th>\n",
       "      <th>ass_assay_type</th>\n",
       "      <th>ass_assay_category</th>\n",
       "      <th>ass_chembl_id</th>\n",
       "      <th>doc_doi</th>\n",
       "      <th>doc_pubmed_id</th>\n",
       "      <th>doc_chembl_id</th>\n",
       "      <th>doc_title</th>\n",
       "      <th>doc_doc_type</th>\n",
       "      <th>doc_abstract</th>\n",
       "      <th>doc_patent_id</th>\n",
       "      <th>coms_canonical_smiles</th>\n",
       "      <th>comp_full_molformula</th>\n",
       "      <th>mold_chembl_id</th>\n",
       "      <th>act_0</th>\n",
       "      <th>act_1</th>\n",
       "      <th>act_2</th>\n",
       "      <th>act_3</th>\n",
       "      <th>act_4</th>\n",
       "      <th>act_5</th>\n",
       "      <th>act_6</th>\n",
       "      <th>act_7</th>\n",
       "      <th>act_8</th>\n",
       "      <th>act_9</th>\n",
       "      <th>act_10</th>\n",
       "      <th>act_11</th>\n",
       "      <th>act_12</th>\n",
       "      <th>act_13</th>\n",
       "      <th>act_14</th>\n",
       "      <th>act_15</th>\n",
       "      <th>act_16</th>\n",
       "      <th>act_17</th>\n",
       "      <th>act_18</th>\n",
       "      <th>act_19</th>\n",
       "      <th>act_20</th>\n",
       "      <th>act_21</th>\n",
       "      <th>act_22</th>\n",
       "      <th>act_23</th>\n",
       "      <th>act_24</th>\n",
       "      <th>act_25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>173</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>941808</td>\n",
       "      <td>Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL2329799</td>\n",
       "      <td>10.1021/jm3017656</td>\n",
       "      <td>23432095</td>\n",
       "      <td>CHEMBL2321830</td>\n",
       "      <td>Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1</td>\n",
       "      <td>C19H16ClNO4</td>\n",
       "      <td>CHEMBL6</td>\n",
       "      <td>0.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>716</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>35936</td>\n",
       "      <td>In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL646844</td>\n",
       "      <td>10.1016/s0960-894x(99)00118-3</td>\n",
       "      <td>10230628</td>\n",
       "      <td>CHEMBL1132082</td>\n",
       "      <td>Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21</td>\n",
       "      <td>C15H14F3NO2</td>\n",
       "      <td>CHEMBL6843</td>\n",
       "      <td>2.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   comp_molregno act_standard_units act_standard_type  act_activity_comment  \\\n",
       "0            173                 nM              EC50                   NaN   \n",
       "1            716                 nM              EC50                   NaN   \n",
       "\n",
       "  act_bao_endpoint act_type ass_assay_id  \\\n",
       "0      BAO_0000188     EC50       941808   \n",
       "1      BAO_0000188     EC50        35936   \n",
       "\n",
       "                                                                                                                                                                                                          ass_description  \\\n",
       "0  Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay   \n",
       "1                                                                                                                   In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.   \n",
       "\n",
       "  ass_assay_type  ass_assay_category  ass_chembl_id  \\\n",
       "0              B                 NaN  CHEMBL2329799   \n",
       "1              F                 NaN   CHEMBL646844   \n",
       "\n",
       "                         doc_doi doc_pubmed_id  doc_chembl_id  \\\n",
       "0              10.1021/jm3017656      23432095  CHEMBL2321830   \n",
       "1  10.1016/s0960-894x(99)00118-3      10230628  CHEMBL1132082   \n",
       "\n",
       "                                                                                                                                                                                           doc_title  \\\n",
       "0  Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.   \n",
       "1                                                                                               Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.   \n",
       "\n",
       "  doc_doc_type  \\\n",
       "0  PUBLICATION   \n",
       "1  PUBLICATION   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                  doc_abstract  \\\n",
       "0  Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...   \n",
       "1  A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...   \n",
       "\n",
       "   doc_patent_id                           coms_canonical_smiles  \\\n",
       "0            NaN  COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1   \n",
       "1            NaN            CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21   \n",
       "\n",
       "  comp_full_molformula mold_chembl_id  act_0  act_1  act_2  act_3  act_4  \\\n",
       "0          C19H16ClNO4        CHEMBL6   0.14    NaN    NaN    NaN    NaN   \n",
       "1          C15H14F3NO2     CHEMBL6843   2.00    NaN    NaN    NaN    NaN   \n",
       "\n",
       "   act_5  act_6  act_7  act_8  act_9  act_10  act_11  act_12  act_13  act_14  \\\n",
       "0    NaN    NaN    NaN    NaN    NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "1    NaN    NaN    NaN    NaN    NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "   act_15  act_16  act_17  act_18  act_19  act_20  act_21  act_22  act_23  \\\n",
       "0     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "1     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "   act_24  act_25  \n",
       "0     NaN     NaN  \n",
       "1     NaN     NaN  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"C:/Users/rbachorz/Projects/qsarmodeler/qsarmodeler/notebooks/ar_homo_sapiens_chembl_3.3_more_ChEMBL_columnsEC50.csv\")\n",
    "df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                                           COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1\n",
       "1                                                     CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21\n",
       "2                                CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1\n",
       "3                                                     CCC1CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1\n",
       "4                                                   CC1(C)CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1\n",
       "                                              ...                                         \n",
       "659                   C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21\n",
       "660                                    O=C1COc2c(Cl)cc(Cl)cc2C(C(=O)Nc2ccc(C(F)(F)F)cc2)N1\n",
       "661    CCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H]([C@@H](C)C[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C\n",
       "662                                   Cc1cc(Cl)cc2c1OCC(=O)NC2C(=O)Nc1ccc([N+](=O)[O-])cc1\n",
       "663                                        C[C@](O)(CCOc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21\n",
       "Name: coms_canonical_smiles, Length: 664, dtype: object"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"coms_canonical_smiles\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>comp_molregno</th>\n",
       "      <th>act_standard_units</th>\n",
       "      <th>act_standard_type</th>\n",
       "      <th>act_activity_comment</th>\n",
       "      <th>act_bao_endpoint</th>\n",
       "      <th>act_type</th>\n",
       "      <th>ass_assay_id</th>\n",
       "      <th>ass_description</th>\n",
       "      <th>ass_assay_type</th>\n",
       "      <th>ass_assay_category</th>\n",
       "      <th>ass_chembl_id</th>\n",
       "      <th>doc_doi</th>\n",
       "      <th>doc_pubmed_id</th>\n",
       "      <th>doc_chembl_id</th>\n",
       "      <th>doc_title</th>\n",
       "      <th>doc_doc_type</th>\n",
       "      <th>doc_abstract</th>\n",
       "      <th>doc_patent_id</th>\n",
       "      <th>coms_canonical_smiles</th>\n",
       "      <th>comp_full_molformula</th>\n",
       "      <th>mold_chembl_id</th>\n",
       "      <th>act_0</th>\n",
       "      <th>act_1</th>\n",
       "      <th>act_2</th>\n",
       "      <th>act_3</th>\n",
       "      <th>act_4</th>\n",
       "      <th>act_5</th>\n",
       "      <th>act_6</th>\n",
       "      <th>act_7</th>\n",
       "      <th>act_8</th>\n",
       "      <th>act_9</th>\n",
       "      <th>act_10</th>\n",
       "      <th>act_11</th>\n",
       "      <th>act_12</th>\n",
       "      <th>act_13</th>\n",
       "      <th>act_14</th>\n",
       "      <th>act_15</th>\n",
       "      <th>act_16</th>\n",
       "      <th>act_17</th>\n",
       "      <th>act_18</th>\n",
       "      <th>act_19</th>\n",
       "      <th>act_20</th>\n",
       "      <th>act_21</th>\n",
       "      <th>act_22</th>\n",
       "      <th>act_23</th>\n",
       "      <th>act_24</th>\n",
       "      <th>act_25</th>\n",
       "      <th>act_std</th>\n",
       "      <th>act_min</th>\n",
       "      <th>act_mean</th>\n",
       "      <th>act_median</th>\n",
       "      <th>act_max</th>\n",
       "      <th>log_act_mean</th>\n",
       "      <th>log_act_median</th>\n",
       "      <th>log_act_min</th>\n",
       "      <th>pEC50_mean</th>\n",
       "      <th>pEC50_median</th>\n",
       "      <th>pEC50_min</th>\n",
       "      <th>meas_count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>173</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>941808</td>\n",
       "      <td>Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL2329799</td>\n",
       "      <td>10.1021/jm3017656</td>\n",
       "      <td>23432095</td>\n",
       "      <td>CHEMBL2321830</td>\n",
       "      <td>Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1</td>\n",
       "      <td>C19H16ClNO4</td>\n",
       "      <td>CHEMBL6</td>\n",
       "      <td>0.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>716</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>35936</td>\n",
       "      <td>In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL646844</td>\n",
       "      <td>10.1016/s0960-894x(99)00118-3</td>\n",
       "      <td>10230628</td>\n",
       "      <td>CHEMBL1132082</td>\n",
       "      <td>Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21</td>\n",
       "      <td>C15H14F3NO2</td>\n",
       "      <td>CHEMBL6843</td>\n",
       "      <td>2.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.00</td>\n",
       "      <td>2.00</td>\n",
       "      <td>2.00</td>\n",
       "      <td>2.00</td>\n",
       "      <td>0.301030</td>\n",
       "      <td>0.301030</td>\n",
       "      <td>0.301030</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   comp_molregno act_standard_units act_standard_type  act_activity_comment  \\\n",
       "0            173                 nM              EC50                   NaN   \n",
       "1            716                 nM              EC50                   NaN   \n",
       "\n",
       "  act_bao_endpoint act_type ass_assay_id  \\\n",
       "0      BAO_0000188     EC50       941808   \n",
       "1      BAO_0000188     EC50        35936   \n",
       "\n",
       "                                                                                                                                                                                                          ass_description  \\\n",
       "0  Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay   \n",
       "1                                                                                                                   In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.   \n",
       "\n",
       "  ass_assay_type  ass_assay_category  ass_chembl_id  \\\n",
       "0              B                 NaN  CHEMBL2329799   \n",
       "1              F                 NaN   CHEMBL646844   \n",
       "\n",
       "                         doc_doi doc_pubmed_id  doc_chembl_id  \\\n",
       "0              10.1021/jm3017656      23432095  CHEMBL2321830   \n",
       "1  10.1016/s0960-894x(99)00118-3      10230628  CHEMBL1132082   \n",
       "\n",
       "                                                                                                                                                                                           doc_title  \\\n",
       "0  Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.   \n",
       "1                                                                                               Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.   \n",
       "\n",
       "  doc_doc_type  \\\n",
       "0  PUBLICATION   \n",
       "1  PUBLICATION   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                  doc_abstract  \\\n",
       "0  Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...   \n",
       "1  A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...   \n",
       "\n",
       "   doc_patent_id                           coms_canonical_smiles  \\\n",
       "0            NaN  COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1   \n",
       "1            NaN            CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21   \n",
       "\n",
       "  comp_full_molformula mold_chembl_id  act_0  act_1  act_2  act_3  act_4  \\\n",
       "0          C19H16ClNO4        CHEMBL6   0.14    NaN    NaN    NaN    NaN   \n",
       "1          C15H14F3NO2     CHEMBL6843   2.00    NaN    NaN    NaN    NaN   \n",
       "\n",
       "   act_5  act_6  act_7  act_8  act_9  act_10  act_11  act_12  act_13  act_14  \\\n",
       "0    NaN    NaN    NaN    NaN    NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "1    NaN    NaN    NaN    NaN    NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "   act_15  act_16  act_17  act_18  act_19  act_20  act_21  act_22  act_23  \\\n",
       "0     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "1     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "   act_24  act_25  act_std  act_min  act_mean  act_median  act_max  \\\n",
       "0     NaN     NaN      0.0     0.14      0.14        0.14     0.14   \n",
       "1     NaN     NaN      0.0     2.00      2.00        2.00     2.00   \n",
       "\n",
       "   log_act_mean  log_act_median  log_act_min  pEC50_mean  pEC50_median  \\\n",
       "0     -0.853872       -0.853872    -0.853872    9.853872      9.853872   \n",
       "1      0.301030        0.301030     0.301030    8.698970      8.698970   \n",
       "\n",
       "   pEC50_min  meas_count  \n",
       "0   9.853872           1  \n",
       "1   8.698970           1  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max_act = 25\n",
    "act_cols = [\"act_\"+str(item) for item in range(max_act)]\n",
    "df[\"act_std\"] = df[act_cols].apply(lambda x: np.std(x), axis=1)\n",
    "df[\"act_min\"] = df[act_cols].apply(lambda x: np.min(x), axis=1)\n",
    "df = df[df[\"act_min\"] > 0]\n",
    "df[\"act_mean\"] = df[act_cols].apply(lambda x: np.mean(x), axis=1)\n",
    "df = df[df[\"act_mean\"] > 0]\n",
    "df[\"act_median\"] = df[act_cols].apply(lambda x: np.nanmedian(x), axis=1)\n",
    "df[\"act_max\"] = df[act_cols].apply(lambda x: np.max(x), axis=1)\n",
    "df[\"log_act_mean\"] = df[act_cols].apply(lambda x: np.log10(np.mean(x)), axis=1)\n",
    "df[\"log_act_median\"] = df[act_cols].apply(lambda x: np.log10(np.nanmedian(x)), axis=1)\n",
    "df[\"log_act_min\"] = df[act_cols].apply(lambda x: np.log10(np.min(x)), axis=1)\n",
    "df[\"pEC50_mean\"] = df[act_cols].apply(lambda x: -1.0*np.log10(np.mean(x) / nm2mol), axis=1)\n",
    "df[\"pEC50_median\"] = df[act_cols].apply(lambda x: -1.0*np.log10(np.nanmedian(x) / nm2mol), axis=1)\n",
    "df[\"pEC50_min\"] = df[act_cols].apply(lambda x: -1.0*np.log10(np.min(x) / nm2mol), axis=1)\n",
    "df[\"meas_count\"] = df[act_cols].apply(lambda x: max_act-np.sum(np.isnan(x)), axis=1)\n",
    "df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: >"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAigAAAGdCAYAAAA44ojeAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAAAwsElEQVR4nO3dfXBUZYL+/ashTUNCEgkxdFpihlGcXQ34c8Hhxd0BhDQyAirW4g6uhS47oyOwpoByBX6Uza68DFsDuGFlnBlKUCobni3FsUoEmmcEZCO7EKUMuMMyNRFBE7MyIS8kdprkfv5wcx6aJEBDmtx9+H6quoq+z93n3FdOwMvTbx5jjBEAAIBFevX0AgAAAC5GQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWCelpxdwNdra2vTll18qPT1dHo+np5cDAACugDFGDQ0NCgQC6tXr0tdIkrKgfPnll8rLy+vpZQAAgKtw6tQpDR48+JJzkrKgpKenS/o2YEZGRrfuOxqNavfu3QoGg/J6vd26bxu4PZ/k/ozkS35uz0i+5JeojPX19crLy3P+O34pSVlQ2p/WycjISEhBSU1NVUZGhit/8dyeT3J/RvIlP7dnJF/yS3TGK3l5Bi+SBQAA1qGgAAAA61BQAACAdSgoAADAOtdUUFatWiWPx6OioiJnzBijUCikQCCgfv36afz48Tp27FjM4yKRiObPn6/s7GylpaVp+vTpOn369LUsBQAAuMhVF5RDhw7pl7/8pYYPHx4zvmbNGq1du1YbNmzQoUOH5Pf7VVhYqIaGBmdOUVGRtm/frtLSUh04cECNjY2aOnWqWltbrz4JAABwjasqKI2NjXr88cf1q1/9SgMGDHDGjTFav369li5dqhkzZqigoEBbtmxRU1OTSkpKJEl1dXXatGmTfv7zn2vSpEm65557tHXrVlVUVGjPnj3dkwoAACS1q/oclLlz5+rBBx/UpEmT9NJLLznjlZWVqq6uVjAYdMZ8Pp/GjRunsrIyPf300yovL1c0Go2ZEwgEVFBQoLKyMk2ePLnD8SKRiCKRiHO/vr5e0rfv045Go1cToUvt++vu/drC7fkk92ckX/Jze0byJb9EZYxnf3EXlNLSUn300Uc6dOhQh23V1dWSpEGDBsWMDxo0SCdPnnTm9OnTJ+bKS/uc9sdfbNWqVVq+fHmH8d27dys1NTXeCFckHA4nZL+2cHs+yf0ZyZf83J6RfMmvuzM2NTVd8dy4CsqpU6f03HPPaffu3erbt2+X8y7+hDhjzGU/Ne5ScxYvXqwFCxY499s/KjcYDCbkk2TD4bAKCwtd+QmBbs8nuT8j+ZKf2zOSL/klKmP7MyBXIq6CUl5erpqaGo0YMcIZa21t1f79+7VhwwYdP35c0rdXSXJzc505NTU1zlUVv9+vlpYW1dbWxlxFqamp0dixYzs9rs/nk8/n6zDu9XoT9suRyH3bwO35JPdnJF/yc3tG8iW/7s4Yz77iepHsxIkTVVFRoSNHjji3kSNH6vHHH9eRI0f03e9+V36/P+aSUEtLi/bt2+eUjxEjRsjr9cbMqaqq0tGjR7ssKAAA4MYS1xWU9PR0FRQUxIylpaVp4MCBznhRUZFWrlypoUOHaujQoVq5cqVSU1M1a9YsSVJmZqbmzJmjhQsXauDAgcrKytKiRYs0bNgwTZo0qZtiAQCAZNbt32b8/PPPq7m5Wc8++6xqa2s1atQo7d69O+arldetW6eUlBTNnDlTzc3NmjhxojZv3qzevXt393IAAEASuuaCsnfv3pj7Ho9HoVBIoVCoy8f07dtXxcXFKi4uvtbDJ0xBaJcird++aPez1Q/28GoAALix8F08AADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGCduArKxo0bNXz4cGVkZCgjI0NjxozRe++952x/8skn5fF4Ym6jR4+O2UckEtH8+fOVnZ2ttLQ0TZ8+XadPn+6eNAAAwBXiKiiDBw/W6tWrdfjwYR0+fFj333+/HnroIR07dsyZ88ADD6iqqsq57dixI2YfRUVF2r59u0pLS3XgwAE1NjZq6tSpam1t7Z5EAAAg6aXEM3natGkx91esWKGNGzfq4MGDuuuuuyRJPp9Pfr+/08fX1dVp06ZNeuONNzRp0iRJ0tatW5WXl6c9e/Zo8uTJV5MBAAC4TFwF5UKtra36t3/7N507d05jxoxxxvfu3aucnBzddNNNGjdunFasWKGcnBxJUnl5uaLRqILBoDM/EAiooKBAZWVlXRaUSCSiSCTi3K+vr5ckRaNRRaPRq43Qqfb9+XqZDmNu0J7FTZku5vaM5Et+bs9IvuSXqIzx7M9jjDGXn/b/q6io0JgxY/TNN9+of//+Kikp0Q9/+ENJ0rZt29S/f3/l5+ersrJSy5Yt0/nz51VeXi6fz6eSkhI99dRTMWVDkoLBoIYMGaJXX32102OGQiEtX768w3hJSYlSU1PjWT4AAOghTU1NmjVrlurq6pSRkXHJuXEXlJaWFn3++ec6e/as3nzzTf3617/Wvn37dOedd3aYW1VVpfz8fJWWlmrGjBldFpTCwkLddttt+sUvftHpMTu7gpKXl6evv/76sgHjFY1GFQ6HtexwL0XaPJKkoyH3PPXUnq+wsFBer7enl5MQbs9IvuTn9ozkS36JylhfX6/s7OwrKihxP8XTp08f3X777ZKkkSNH6tChQ3r55Zc7vfqRm5ur/Px8nThxQpLk9/vV0tKi2tpaDRgwwJlXU1OjsWPHdnlMn88nn8/XYdzr9SbslyPS5lGk1eMcx20S+bOzhdszki/5uT0j+ZJfd2eMZ1/X/DkoxpgOV0TanTlzRqdOnVJubq4kacSIEfJ6vQqHw86cqqoqHT169JIFBQAA3FjiuoKyZMkSTZkyRXl5eWpoaFBpaan27t2rnTt3qrGxUaFQSI8++qhyc3P12WefacmSJcrOztYjjzwiScrMzNScOXO0cOFCDRw4UFlZWVq0aJGGDRvmvKsHAAAgroLy1Vdf6YknnlBVVZUyMzM1fPhw7dy5U4WFhWpublZFRYVef/11nT17Vrm5uZowYYK2bdum9PR0Zx/r1q1TSkqKZs6cqebmZk2cOFGbN29W7969uz0cAABITnEVlE2bNnW5rV+/ftq1a9dl99G3b18VFxeruLg4nkMDAIAbCN/FAwAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsE1dB2bhxo4YPH66MjAxlZGRozJgxeu+995ztxhiFQiEFAgH169dP48eP17Fjx2L2EYlENH/+fGVnZystLU3Tp0/X6dOnuycNAABwhbgKyuDBg7V69WodPnxYhw8f1v3336+HHnrIKSFr1qzR2rVrtWHDBh06dEh+v1+FhYVqaGhw9lFUVKTt27ertLRUBw4cUGNjo6ZOnarW1tbuTQYAAJJWXAVl2rRp+uEPf6g77rhDd9xxh1asWKH+/fvr4MGDMsZo/fr1Wrp0qWbMmKGCggJt2bJFTU1NKikpkSTV1dVp06ZN+vnPf65Jkybpnnvu0datW1VRUaE9e/YkJCAAAEg+V/0alNbWVpWWlurcuXMaM2aMKisrVV1drWAw6Mzx+XwaN26cysrKJEnl5eWKRqMxcwKBgAoKCpw5AAAAKfE+oKKiQmPGjNE333yj/v37a/v27brzzjudgjFo0KCY+YMGDdLJkyclSdXV1erTp48GDBjQYU51dXWXx4xEIopEIs79+vp6SVI0GlU0Go03wiW178/Xy3QYc4P2LG7KdDG3ZyRf8nN7RvIlv0RljGd/cReU733vezpy5IjOnj2rN998U7Nnz9a+ffuc7R6PJ2a+MabD2MUuN2fVqlVavnx5h/Hdu3crNTU1zgRX5h9Htjl/3rFjR0KO0ZPC4XBPLyHh3J6RfMnP7RnJl/y6O2NTU9MVz427oPTp00e33367JGnkyJE6dOiQXn75Zf393/+9pG+vkuTm5jrza2pqnKsqfr9fLS0tqq2tjbmKUlNTo7Fjx3Z5zMWLF2vBggXO/fr6euXl5SkYDCojIyPeCJcUjUYVDoe17HAvRdq+LU1HQ5O79Rg9qT1fYWGhvF5vTy8nIdyekXzJz+0ZyZf8EpWx/RmQKxF3QbmYMUaRSERDhgyR3+9XOBzWPffcI0lqaWnRvn379LOf/UySNGLECHm9XoXDYc2cOVOSVFVVpaNHj2rNmjVdHsPn88nn83UY93q9CfvliLR5FGn1OMdxm0T+7Gzh9ozkS35uz0i+5NfdGePZV1wFZcmSJZoyZYry8vLU0NCg0tJS7d27Vzt37pTH41FRUZFWrlypoUOHaujQoVq5cqVSU1M1a9YsSVJmZqbmzJmjhQsXauDAgcrKytKiRYs0bNgwTZo0Kb6UAADAteIqKF999ZWeeOIJVVVVKTMzU8OHD9fOnTtVWFgoSXr++efV3NysZ599VrW1tRo1apR2796t9PR0Zx/r1q1TSkqKZs6cqebmZk2cOFGbN29W7969uzcZAABIWnEVlE2bNl1yu8fjUSgUUigU6nJO3759VVxcrOLi4ngODQAAbiB8Fw8AALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWCeugrJq1Srde++9Sk9PV05Ojh5++GEdP348Zs6TTz4pj8cTcxs9enTMnEgkovnz5ys7O1tpaWmaPn26Tp8+fe1pAACAK8RVUPbt26e5c+fq4MGDCofDOn/+vILBoM6dOxcz74EHHlBVVZVz27FjR8z2oqIibd++XaWlpTpw4IAaGxs1depUtba2XnsiAACQ9FLimbxz586Y+6+99ppycnJUXl6uH/zgB864z+eT3+/vdB91dXXatGmT3njjDU2aNEmStHXrVuXl5WnPnj2aPHlyvBkAAIDLxFVQLlZXVydJysrKihnfu3evcnJydNNNN2ncuHFasWKFcnJyJEnl5eWKRqMKBoPO/EAgoIKCApWVlXVaUCKRiCKRiHO/vr5ekhSNRhWNRq8lQgft+/P1Mh3G3KA9i5syXcztGcmX/NyekXzJL1EZ49mfxxhjLj+tI2OMHnroIdXW1uqDDz5wxrdt26b+/fsrPz9flZWVWrZsmc6fP6/y8nL5fD6VlJToqaeeiikckhQMBjVkyBC9+uqrHY4VCoW0fPnyDuMlJSVKTU29muUDAIDrrKmpSbNmzVJdXZ0yMjIuOfeqr6DMmzdPn3zyiQ4cOBAz/thjjzl/Ligo0MiRI5Wfn693331XM2bM6HJ/xhh5PJ5Oty1evFgLFixw7tfX1ysvL0/BYPCyAeMVjUYVDoe17HAvRdq+Xc/RkHuedmrPV1hYKK/X29PLSQi3ZyRf8nN7RvIlv0RlbH8G5EpcVUGZP3++3nnnHe3fv1+DBw++5Nzc3Fzl5+frxIkTkiS/36+WlhbV1tZqwIABzryamhqNHTu20334fD75fL4O416vN2G/HJE2jyKtHuc4bpPIn50t3J6RfMnP7RnJl/y6O2M8+4rrXTzGGM2bN09vvfWWfvvb32rIkCGXfcyZM2d06tQp5ebmSpJGjBghr9ercDjszKmqqtLRo0e7LCgAAODGEtcVlLlz56qkpES/+c1vlJ6erurqaklSZmam+vXrp8bGRoVCIT366KPKzc3VZ599piVLlig7O1uPPPKIM3fOnDlauHChBg4cqKysLC1atEjDhg1z3tUDAABubHEVlI0bN0qSxo8fHzP+2muv6cknn1Tv3r1VUVGh119/XWfPnlVubq4mTJigbdu2KT093Zm/bt06paSkaObMmWpubtbEiRO1efNm9e7d+9oTAQCApBdXQbncG3769eunXbt2XXY/ffv2VXFxsYqLi+M5PAAAuEHwXTwAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYJ24CsqqVat07733Kj09XTk5OXr44Yd1/PjxmDnGGIVCIQUCAfXr10/jx4/XsWPHYuZEIhHNnz9f2dnZSktL0/Tp03X69OlrTwMAAFwhroKyb98+zZ07VwcPHlQ4HNb58+cVDAZ17tw5Z86aNWu0du1abdiwQYcOHZLf71dhYaEaGhqcOUVFRdq+fbtKS0t14MABNTY2aurUqWptbe2+ZAAAIGmlxDN5586dMfdfe+015eTkqLy8XD/4wQ9kjNH69eu1dOlSzZgxQ5K0ZcsWDRo0SCUlJXr66adVV1enTZs26Y033tCkSZMkSVu3blVeXp727NmjyZMnd1M0AACQrOIqKBerq6uTJGVlZUmSKisrVV1drWAw6Mzx+XwaN26cysrK9PTTT6u8vFzRaDRmTiAQUEFBgcrKyjotKJFIRJFIxLlfX18vSYpGo4pGo9cSoYP2/fl6mQ5jbtCexU2ZLub2jORLfm7PSL7kl6iM8ezPY4wxl5/WkTFGDz30kGpra/XBBx9IksrKynTffffpiy++UCAQcOb+5Cc/0cmTJ7Vr1y6VlJToqaeeiikckhQMBjVkyBC9+uqrHY4VCoW0fPnyDuMlJSVKTU29muUDAIDrrKmpSbNmzVJdXZ0yMjIuOfeqr6DMmzdPn3zyiQ4cONBhm8fjiblvjOkwdrFLzVm8eLEWLFjg3K+vr1deXp6CweBlA8YrGo0qHA5r2eFeirR9u56jIfc87dSer7CwUF6vt6eXkxBuz0i+5Of2jORLfonK2P4MyJW4qoIyf/58vfPOO9q/f78GDx7sjPv9fklSdXW1cnNznfGamhoNGjTImdPS0qLa2loNGDAgZs7YsWM7PZ7P55PP5+sw7vV6E/bLEWnzKNLqcY7jNon82dnC7RnJl/zcnpF8ya+7M8azr7jexWOM0bx58/TWW2/pt7/9rYYMGRKzfciQIfL7/QqHw85YS0uL9u3b55SPESNGyOv1xsypqqrS0aNHuywoAADgxhLXFZS5c+eqpKREv/nNb5Senq7q6mpJUmZmpvr16yePx6OioiKtXLlSQ4cO1dChQ7Vy5UqlpqZq1qxZztw5c+Zo4cKFGjhwoLKysrRo0SINGzbMeVcPAAC4scVVUDZu3ChJGj9+fMz4a6+9pieffFKS9Pzzz6u5uVnPPvusamtrNWrUKO3evVvp6enO/HXr1iklJUUzZ85Uc3OzJk6cqM2bN6t3797XlgYAALhCXAXlSt7w4/F4FAqFFAqFupzTt29fFRcXq7i4OJ7DAwCAGwTfxQMAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1om7oOzfv1/Tpk1TIBCQx+PR22+/HbP9ySeflMfjibmNHj06Zk4kEtH8+fOVnZ2ttLQ0TZ8+XadPn76mIAAAwD3iLijnzp3T3XffrQ0bNnQ554EHHlBVVZVz27FjR8z2oqIibd++XaWlpTpw4IAaGxs1depUtba2xp8AAAC4Tkq8D5gyZYqmTJlyyTk+n09+v7/TbXV1ddq0aZPeeOMNTZo0SZK0detW5eXlac+ePZo8eXK8SwIAAC4Td0G5Env37lVOTo5uuukmjRs3TitWrFBOTo4kqby8XNFoVMFg0JkfCARUUFCgsrKyTgtKJBJRJBJx7tfX10uSotGootFot669fX++XqbDmBu0Z3FTpou5PSP5kp/bM5Iv+SUqYzz78xhjzOWndfFgj0fbt2/Xww8/7Ixt27ZN/fv3V35+viorK7Vs2TKdP39e5eXl8vl8Kikp0VNPPRVTOCQpGAxqyJAhevXVVzscJxQKafny5R3GS0pKlJqaerXLBwAA11FTU5NmzZqluro6ZWRkXHJut19Beeyxx5w/FxQUaOTIkcrPz9e7776rGTNmdPk4Y4w8Hk+n2xYvXqwFCxY49+vr65WXl6dgMHjZgPGKRqMKh8NadriXIm3frudoyD1PO7XnKywslNfr7enlJITbM5Iv+bk9I/mSX6Iytj8DciUS8hTPhXJzc5Wfn68TJ05Ikvx+v1paWlRbW6sBAwY482pqajR27NhO9+Hz+eTz+TqMe73ehP1yRNo8irR6nOO4TSJ/drZwe0byJT+3ZyRf8uvujPHsK+Gfg3LmzBmdOnVKubm5kqQRI0bI6/UqHA47c6qqqnT06NEuCwoAALixxH0FpbGxUb///e+d+5WVlTpy5IiysrKUlZWlUCikRx99VLm5ufrss8+0ZMkSZWdn65FHHpEkZWZmas6cOVq4cKEGDhyorKwsLVq0SMOGDXPe1QMAAG5scReUw4cPa8KECc799teGzJ49Wxs3blRFRYVef/11nT17Vrm5uZowYYK2bdum9PR05zHr1q1TSkqKZs6cqebmZk2cOFGbN29W7969uyESAABIdnEXlPHjx+tSb/zZtWvXZffRt29fFRcXq7i4ON7DAwCAGwDfxQMAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOuk9PQCgGv1nRfejbnv62205vs9tBgAQLfgCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHXiLij79+/XtGnTFAgE5PF49Pbbb8dsN8YoFAopEAioX79+Gj9+vI4dOxYzJxKJaP78+crOzlZaWpqmT5+u06dPX1MQAADgHnEXlHPnzunuu+/Whg0bOt2+Zs0arV27Vhs2bNChQ4fk9/tVWFiohoYGZ05RUZG2b9+u0tJSHThwQI2NjZo6dapaW1uvPgkAAHCNuD+obcqUKZoyZUqn24wxWr9+vZYuXaoZM2ZIkrZs2aJBgwappKRETz/9tOrq6rRp0ya98cYbmjRpkiRp69atysvL0549ezR58uRriAMAANygWz9JtrKyUtXV1QoGg86Yz+fTuHHjVFZWpqefflrl5eWKRqMxcwKBgAoKClRWVtZpQYlEIopEIs79+vp6SVI0GlU0Gu3OCM7+fL1MhzE3aM/ipky+3ib2/v+eOzdlvJAbz+GF3J5Pcn9G8iW/RGWMZ3/dWlCqq6slSYMGDYoZHzRokE6ePOnM6dOnjwYMGNBhTvvjL7Zq1SotX768w/ju3buVmpraHUvv4B9Htjl/3rFjR0KO0ZPC4XBPL6HbdPWx9m7K2BnyJT+3ZyRf8uvujE1NTVc8NyHfxePxeGLuG2M6jF3sUnMWL16sBQsWOPfr6+uVl5enYDCojIyMa1/wBaLRqMLhsJYd7qVI27frORpyz9NO7fkKCwvl9Xp7ejndoiC0K+a+r5fRP45sc1XGC7nxHF7I7fkk92ckX/JLVMb2Z0CuRLcWFL/fL+nbqyS5ubnOeE1NjXNVxe/3q6WlRbW1tTFXUWpqajR27NhO9+vz+eTz+TqMe73ehP1yRNo8irR6nOO4TSJ/dtdb+3m6mJsydoZ8yc/tGcmX/Lo7Yzz76tbPQRkyZIj8fn/MJaGWlhbt27fPKR8jRoyQ1+uNmVNVVaWjR492WVAAAMCNJe4rKI2Njfr973/v3K+srNSRI0eUlZWlW2+9VUVFRVq5cqWGDh2qoUOHauXKlUpNTdWsWbMkSZmZmZozZ44WLlyogQMHKisrS4sWLdKwYcOcd/UAAIAbW9wF5fDhw5owYYJzv/21IbNnz9bmzZv1/PPPq7m5Wc8++6xqa2s1atQo7d69W+np6c5j1q1bp5SUFM2cOVPNzc2aOHGiNm/erN69e3dDJAAAkOziLijjx4+XMabL7R6PR6FQSKFQqMs5ffv2VXFxsYqLi+M9PAAAuAHwXTwAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDrdXlBCoZA8Hk/Mze/3O9uNMQqFQgoEAurXr5/Gjx+vY8eOdfcyAABAEkvIFZS77rpLVVVVzq2iosLZtmbNGq1du1YbNmzQoUOH5Pf7VVhYqIaGhkQsBQAAJKGEFJSUlBT5/X7ndvPNN0v69urJ+vXrtXTpUs2YMUMFBQXasmWLmpqaVFJSkoilAACAJJSSiJ2eOHFCgUBAPp9Po0aN0sqVK/Xd735XlZWVqq6uVjAYdOb6fD6NGzdOZWVlevrppzvdXyQSUSQSce7X19dLkqLRqKLRaLeuvX1/vl6mw5gbtGdxUyZfbxN7/3/PnZsyXsiN5/BCbs8nuT8j+ZJfojLGsz+PMcZcftqVe++999TU1KQ77rhDX331lV566SX97ne/07Fjx3T8+HHdd999+uKLLxQIBJzH/OQnP9HJkye1a9euTvcZCoW0fPnyDuMlJSVKTU3tzuUDAIAEaWpq0qxZs1RXV6eMjIxLzu32gnKxc+fO6bbbbtPzzz+v0aNH67777tOXX36p3NxcZ86Pf/xjnTp1Sjt37ux0H51dQcnLy9PXX3992YDxikajCofDWna4lyJtHknS0dDkbj1GT2rPV1hYKK/X29PL6RYFodhi6+tl9I8j21yV8UJuPIcXcns+yf0ZyZf8EpWxvr5e2dnZV1RQEvIUz4XS0tI0bNgwnThxQg8//LAkqbq6Oqag1NTUaNCgQV3uw+fzyefzdRj3er0J++WItHkUafU4x3GbRP7srrf283QxN2XsDPmSn9szki/5dXfGePaV8M9BiUQi+q//+i/l5uZqyJAh8vv9CofDzvaWlhbt27dPY8eOTfRSAABAkuj2KyiLFi3StGnTdOutt6qmpkYvvfSS6uvrNXv2bHk8HhUVFWnlypUaOnSohg4dqpUrVyo1NVWzZs3q7qUAAIAk1e0F5fTp0/rRj36kr7/+WjfffLNGjx6tgwcPKj8/X5L0/PPPq7m5Wc8++6xqa2s1atQo7d69W+np6d29FAAAkKS6vaCUlpZecrvH41EoFFIoFOruQwMAAJdI+ItkcWnfeeHdmPufrX6wh1YCAIA9+LJAAABgHQoKAACwDgUFAABYh4ICAACsQ0EBAADWoaAAAADrUFAAAIB1KCgAAMA6FBQAAGAdCgoAALAOBQUAAFiHggIAAKxDQQEAANahoAAAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1knp6QUkg++88G6Hsc9WP9gDK7k233nhXfl6G635vlQQ2qVIqycpcwAA3I8rKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArMO7eK7Sxe/s4d0wAC6n/d+NC99Nd3zF1B5eFWAnrqAAAADrUFAAAIB1KCgAAMA6vAYlgXidCgAAV4eCghhu+Vh/AEBy69GC8sorr+if/umfVFVVpbvuukvr16/XX/zFX/Tkkm44nRUSAAB6Wo8VlG3btqmoqEivvPKK7rvvPr366quaMmWKPv30U9166609tSwAPeDCotz+FlwAN7YeKyhr167VnDlz9Ld/+7eSpPXr12vXrl3auHGjVq1a1VPLumrddSXCLU+xXG2O6/m6ne46VqLW7JbfBQC4Gj1SUFpaWlReXq4XXnghZjwYDKqsrKzD/Egkokgk4tyvq6uTJP3xj39UNBrt1rVFo1E1NTUpJdpLrW2ebt337Yv+nw5jV3ICzpw50y3HTzl/TiltRk1NbXHlu5Ljj1r1/8Yeq5M5F+f/j8UTO13jpR7TmYuP1Z7xzJkz8nq9na6vs8d1lvPix13Jmq/m59WZzn6GZ86ccX5HL8x3rcfqTGdZL7fvK3lMZy78Gbafv/+z9C1FLvgdvdp926Q954V/D7vr7/fV6q5zeOF+fL2M/u89bVf8O5ps4v07mAwu/j1I1DlsaGiQJBljLj/Z9IAvvvjCSDL//u//HjO+YsUKc8cdd3SY/+KLLxpJ3Lhx48aNGzcX3E6dOnXZrtCjL5L1eGL/D94Y02FMkhYvXqwFCxY499va2vTHP/5RAwcO7HT+taivr1deXp5OnTqljIyMbt23DdyeT3J/RvIlP7dnJF/yS1RGY4waGhoUCAQuO7dHCkp2drZ69+6t6urqmPGamhoNGjSow3yfzyefzxczdtNNNyVyicrIyHDtL57k/nyS+zOSL/m5PSP5kl8iMmZmZl7RvB75JNk+ffpoxIgRCofDMePhcFhjx47tiSUBAACL9NhTPAsWLNATTzyhkSNHasyYMfrlL3+pzz//XM8880xPLQkAAFiixwrKY489pjNnzugf/uEfVFVVpYKCAu3YsUP5+fk9tSRJ3z6d9OKLL3Z4Sskt3J5Pcn9G8iU/t2ckX/KzIaPHmCt5rw8AAMD1w7cZAwAA61BQAACAdSgoAADAOhQUAABgHQrKBV555RUNGTJEffv21YgRI/TBBx/09JI6FQqF5PF4Ym5+v9/ZboxRKBRSIBBQv379NH78eB07dixmH5FIRPPnz1d2drbS0tI0ffp0nT59OmZObW2tnnjiCWVmZiozM1NPPPGEzp492+159u/fr2nTpikQCMjj8ejtt9+O2X4983z++eeaNm2a0tLSlJ2drb/7u79TS0tLQvM9+eSTHc7n6NGjkybfqlWrdO+99yo9PV05OTl6+OGHdfz48Zg5yX4OryRjMp/HjRs3avjw4c6Hco0ZM0bvvfeesz3Zz9/l8iXzuevMqlWr5PF4VFRU5Iwl5Tm81u/VcYvS0lLj9XrNr371K/Ppp5+a5557zqSlpZmTJ0/29NI6ePHFF81dd91lqqqqnFtNTY2zffXq1SY9Pd28+eabpqKiwjz22GMmNzfX1NfXO3OeeeYZc8stt5hwOGw++ugjM2HCBHP33Xeb8+fPO3MeeOABU1BQYMrKykxZWZkpKCgwU6dO7fY8O3bsMEuXLjVvvvmmkWS2b98es/165Tl//rwpKCgwEyZMMB999JEJh8MmEAiYefPmJTTf7NmzzQMPPBBzPs+cORMzx+Z8kydPNq+99po5evSoOXLkiHnwwQfNrbfeahobG505yX4OryRjMp/Hd955x7z77rvm+PHj5vjx42bJkiXG6/Wao0ePGmOS//xdLl8yn7uL/ed//qf5zne+Y4YPH26ee+45ZzwZzyEF5X99//vfN88880zM2J/8yZ+YF154oYdW1LUXX3zR3H333Z1ua2trM36/36xevdoZ++abb0xmZqb5xS9+YYwx5uzZs8br9ZrS0lJnzhdffGF69epldu7caYwx5tNPPzWSzMGDB505H374oZFkfve73yUg1bcu/g/49cyzY8cO06tXL/PFF184c/71X//V+Hw+U1dXl5B8xnz7j+NDDz3U5WOSKZ8xxtTU1BhJZt++fcYY953DzjIa477zOGDAAPPrX//alefvwnzGuOfcNTQ0mKFDh5pwOGzGjRvnFJRkPYc8xSOppaVF5eXlCgaDMePBYFBlZWU9tKpLO3HihAKBgIYMGaK/+qu/0h/+8AdJUmVlpaqrq2Oy+Hw+jRs3zslSXl6uaDQaMycQCKigoMCZ8+GHHyozM1OjRo1y5owePVqZmZnX9WdyPfN8+OGHKigoiPkSq8mTJysSiai8vDyhOffu3aucnBzdcccd+vGPf6yamhpnW7Llq6urkyRlZWVJcuc5vDhjOzecx9bWVpWWlurcuXMaM2aM687fxfnaueHczZ07Vw8++KAmTZoUM56s57BHv83YFl9//bVaW1s7fFHhoEGDOnyhoQ1GjRql119/XXfccYe++uorvfTSSxo7dqyOHTvmrLezLCdPnpQkVVdXq0+fPhowYECHOe2Pr66uVk5OTodj5+TkXNefyfXMU11d3eE4AwYMUJ8+fRKaecqUKfrLv/xL5efnq7KyUsuWLdP999+v8vJy+Xy+pMpnjNGCBQv053/+5yooKHCO277ei9efjOews4xS8p/HiooKjRkzRt9884369++v7du3684773T+w5Ps56+rfFLynztJKi0t1UcffaRDhw512JasfwcpKBfweDwx940xHcZsMGXKFOfPw4YN05gxY3Tbbbdpy5Ytzgu7ribLxXM6m99TP5PrlacnMj/22GPOnwsKCjRy5Ejl5+fr3Xff1YwZM7p8nI355s2bp08++UQHDhzosM0t57CrjMl+Hr/3ve/pyJEjOnv2rN58803Nnj1b+/bt6/KYyXb+usp35513Jv25O3XqlJ577jnt3r1bffv27XJesp1DnuKRlJ2drd69e3dodzU1NR2aoI3S0tI0bNgwnThxwnk3z6Wy+P1+tbS0qLa29pJzvvrqqw7H+p//+Z/r+jO5nnn8fn+H49TW1ioajV7XzLm5ucrPz9eJEyecdSVDvvnz5+udd97R+++/r8GDBzvjbjqHXWXsTLKdxz59+uj222/XyJEjtWrVKt199916+eWXXXP+usrXmWQ7d+Xl5aqpqdGIESOUkpKilJQU7du3T//8z/+slJQUZ99Jdw7jesWKi33/+983P/3pT2PG/vRP/9TKF8le7JtvvjG33HKLWb58ufNiqJ/97GfO9kgk0umLobZt2+bM+fLLLzt9MdR//Md/OHMOHjzYYy+SvR552l/c9eWXXzpzSktLE/4i2Yt9/fXXxufzmS1btiRFvra2NjN37lwTCATMf//3f3e6PdnP4eUydibZzuPF7r//fjN79mxXnL9L5etMsp27+vp6U1FREXMbOXKk+eu//mtTUVGRtOeQgvK/2t9mvGnTJvPpp5+aoqIik5aWZj777LOeXloHCxcuNHv37jV/+MMfzMGDB83UqVNNenq6s9bVq1ebzMxM89Zbb5mKigrzox/9qNO3kw0ePNjs2bPHfPTRR+b+++/v9O1kw4cPNx9++KH58MMPzbBhwxLyNuOGhgbz8ccfm48//thIMmvXrjUff/yx8xbv65Wn/e1xEydONB999JHZs2ePGTx48DW/BfBS+RoaGszChQtNWVmZqaysNO+//74ZM2aMueWWW5Im309/+lOTmZlp9u7dG/M2zaamJmdOsp/Dy2VM9vO4ePFis3//flNZWWk++eQTs2TJEtOrVy+ze/duY0zyn79L5Uv2c9eVC9/FY0xynkMKygX+5V/+xeTn55s+ffqYP/uzP4t5C6FN2t+/7vV6TSAQMDNmzDDHjh1ztre1tZkXX3zR+P1+4/P5zA9+8ANTUVERs4/m5mYzb948k5WVZfr162emTp1qPv/885g5Z86cMY8//rhJT0836enp5vHHHze1tbXdnuf99983kjrc2v/v5nrmOXnypHnwwQdNv379TFZWlpk3b5755ptvEpavqanJBINBc/PNNxuv12tuvfVWM3v27A5rtzlfZ9kkmddee82Zk+zn8HIZk/08/s3f/I3zb9/NN99sJk6c6JQTY5L//F0qX7Kfu65cXFCS8Rx6jDEmvieFAAAAEosXyQIAAOtQUAAAgHUoKAAAwDoUFAAAYB0KCgAAsA4FBQAAWIeCAgAArENBAQAA1qGgAAAA61BQAACAdSgoAADAOhQUAABgnf8Pq9j+86jd/EYAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df[\"act_mean\"].hist(bins=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 1.0, 'Conflicting EC50 values')"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data = df[df[\"act_std\"] > 100][\"act_std\"]\n",
    "plt.hist(data, bins=50)\n",
    "plt.grid()\n",
    "plt.xlabel(\"Standard deviation of IC50\", fontsize=14)\n",
    "plt.ylabel(\"Compounds count\", fontsize=14)\n",
    "plt.title(\"Conflicting EC50 values\", fontsize=16)\n",
    "# plt.savefig(\"C:\\\\Users\\\\rbachorz\\\\Projects\\\\rorgammaaidd\\\\presentation\\\\IC50_std_distribution.svg\", dpi=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "13.551020408163266"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape[0]/data.shape[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# def median_incorporate_expert(x, n_acts=15, aqa_position=15):\n",
    "#     aqa_position = 15\n",
    "#     if x[aqa_position] == \"all bad\": \n",
    "#         return None\n",
    "#     n_available_acts = n_acts - x[:n_acts].isna().sum()\n",
    "#     if n_available_acts == 1:\n",
    "#         return x[0]\n",
    "#     elif n_available_acts > 1:\n",
    "#         if pd.isna(x[aqa_position]):\n",
    "#             return np.nanmedian(x[:n_acts])\n",
    "#         else:\n",
    "#             valueable_activities = x.iloc[x[aqa_position].split(\";\")]\n",
    "#             return np.nanmedian(valueable_activities)\n",
    "#     elif n_available_acts < 1:\n",
    "#         raise NotImplementedError\n",
    "    \n",
    "# def mean_incorporate_expert(x, n_acts=15, aqa_position=15):\n",
    "#     aqa_position = 15\n",
    "#     if x[aqa_position] == \"all bad\": \n",
    "#         return None\n",
    "#     n_available_acts = n_acts - x[:n_acts].isna().sum()\n",
    "#     if n_available_acts == 1:\n",
    "#         return x[0]\n",
    "#     elif n_available_acts > 1:\n",
    "#         if pd.isna(x[aqa_position]):\n",
    "#             return np.mean(x[:n_acts])\n",
    "#         else:\n",
    "#             valueable_activities = x.iloc[x[aqa_position].split(\";\")]\n",
    "#             return np.mean(valueable_activities)\n",
    "#     elif n_available_acts < 1:\n",
    "#         raise NotImplementedError\n",
    "\n",
    "# def min_incorporate_expert(x, n_acts=15, aqa_position=15):\n",
    "#     aqa_position = 15\n",
    "#     if x[aqa_position] == \"all bad\": \n",
    "#         return None\n",
    "#     n_available_acts = n_acts - x[:n_acts].isna().sum()\n",
    "#     if n_available_acts == 1:\n",
    "#         return x[0]\n",
    "#     elif n_available_acts > 1:\n",
    "#         if pd.isna(x[aqa_position]):\n",
    "#             return np.min(x[:n_acts])\n",
    "#         else:\n",
    "#             valueable_activities = x.iloc[x[aqa_position].split(\";\")]\n",
    "#             return np.min(valueable_activities)\n",
    "#     elif n_available_acts < 1:\n",
    "#         raise NotImplementedError "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# df[\"act_mean_expert\"] = df[act_cols+[\"Qualitative assay assessment\"]].apply(mean_incorporate_expert, axis=1)\n",
    "# df[\"act_median_expert\"] = df[act_cols+[\"Qualitative assay assessment\"]].apply(median_incorporate_expert, axis=1)\n",
    "# df[\"act_min_expert\"] = df[act_cols+[\"Qualitative assay assessment\"]].apply(min_incorporate_expert, axis=1)\n",
    "\n",
    "# df[\"pIC50_mean_expert\"] = df[\"act_mean_expert\"].apply(lambda x: -1.0*np.log10(x/nm2mol))\n",
    "# df[\"pIC50_median_expert\"] = df[\"act_median_expert\"].apply(lambda x: -1.0*np.log10(x/nm2mol))\n",
    "# df[\"pIC50_min_expert\"] = df[\"act_min_expert\"].apply(lambda x: -1.0*np.log10(x/nm2mol))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "activity_thresholds = [1000, 2000, 3000, 4000, 5000]\n",
    "for at in activity_thresholds:\n",
    "    df[\"class_activity_mean_\"+str(at)] = df[\"act_mean\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "    # df[\"class_activity_mean_expert_\"+str(at)] = df[\"act_mean_expert\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "\n",
    "    df[\"class_activity_median_\"+str(at)] = df[\"act_median\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "    # df[\"class_activity_median_expert_\"+str(at)] = df[\"act_median_expert\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "\n",
    "    df[\"class_activity_min_\"+str(at)] = df[\"act_min\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "    # df[\"class_activity_min_expert_\"+str(at)] = df[\"act_min_expert\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "\n",
    "    df[\"class_activity_max_\"+str(at)] = df[\"act_max\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")\n",
    "    # df[\"class_activity_min_expert_\"+str(at)] = df[\"act_min_expert\"].apply(lambda x: \"ACTIVE\" if x < at else \"INACTIVE\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>comp_molregno</th>\n",
       "      <th>act_standard_units</th>\n",
       "      <th>act_standard_type</th>\n",
       "      <th>act_activity_comment</th>\n",
       "      <th>act_bao_endpoint</th>\n",
       "      <th>act_type</th>\n",
       "      <th>ass_assay_id</th>\n",
       "      <th>ass_description</th>\n",
       "      <th>ass_assay_type</th>\n",
       "      <th>ass_assay_category</th>\n",
       "      <th>ass_chembl_id</th>\n",
       "      <th>doc_doi</th>\n",
       "      <th>doc_pubmed_id</th>\n",
       "      <th>doc_chembl_id</th>\n",
       "      <th>doc_title</th>\n",
       "      <th>doc_doc_type</th>\n",
       "      <th>doc_abstract</th>\n",
       "      <th>doc_patent_id</th>\n",
       "      <th>coms_canonical_smiles</th>\n",
       "      <th>comp_full_molformula</th>\n",
       "      <th>mold_chembl_id</th>\n",
       "      <th>act_0</th>\n",
       "      <th>act_1</th>\n",
       "      <th>act_2</th>\n",
       "      <th>act_3</th>\n",
       "      <th>act_4</th>\n",
       "      <th>act_5</th>\n",
       "      <th>act_6</th>\n",
       "      <th>act_7</th>\n",
       "      <th>act_8</th>\n",
       "      <th>act_9</th>\n",
       "      <th>act_10</th>\n",
       "      <th>act_11</th>\n",
       "      <th>act_12</th>\n",
       "      <th>act_13</th>\n",
       "      <th>act_14</th>\n",
       "      <th>act_15</th>\n",
       "      <th>act_16</th>\n",
       "      <th>act_17</th>\n",
       "      <th>act_18</th>\n",
       "      <th>act_19</th>\n",
       "      <th>act_20</th>\n",
       "      <th>act_21</th>\n",
       "      <th>act_22</th>\n",
       "      <th>act_23</th>\n",
       "      <th>act_24</th>\n",
       "      <th>act_25</th>\n",
       "      <th>act_std</th>\n",
       "      <th>act_min</th>\n",
       "      <th>act_mean</th>\n",
       "      <th>act_median</th>\n",
       "      <th>act_max</th>\n",
       "      <th>log_act_mean</th>\n",
       "      <th>log_act_median</th>\n",
       "      <th>log_act_min</th>\n",
       "      <th>pEC50_mean</th>\n",
       "      <th>pEC50_median</th>\n",
       "      <th>pEC50_min</th>\n",
       "      <th>meas_count</th>\n",
       "      <th>class_activity_mean_1000</th>\n",
       "      <th>class_activity_median_1000</th>\n",
       "      <th>class_activity_min_1000</th>\n",
       "      <th>class_activity_max_1000</th>\n",
       "      <th>class_activity_mean_2000</th>\n",
       "      <th>class_activity_median_2000</th>\n",
       "      <th>class_activity_min_2000</th>\n",
       "      <th>class_activity_max_2000</th>\n",
       "      <th>class_activity_mean_3000</th>\n",
       "      <th>class_activity_median_3000</th>\n",
       "      <th>class_activity_min_3000</th>\n",
       "      <th>class_activity_max_3000</th>\n",
       "      <th>class_activity_mean_4000</th>\n",
       "      <th>class_activity_median_4000</th>\n",
       "      <th>class_activity_min_4000</th>\n",
       "      <th>class_activity_max_4000</th>\n",
       "      <th>class_activity_mean_5000</th>\n",
       "      <th>class_activity_median_5000</th>\n",
       "      <th>class_activity_min_5000</th>\n",
       "      <th>class_activity_max_5000</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>173</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>941808</td>\n",
       "      <td>Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL2329799</td>\n",
       "      <td>10.1021/jm3017656</td>\n",
       "      <td>23432095</td>\n",
       "      <td>CHEMBL2321830</td>\n",
       "      <td>Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1</td>\n",
       "      <td>C19H16ClNO4</td>\n",
       "      <td>CHEMBL6</td>\n",
       "      <td>0.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.140000</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>716</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>35936</td>\n",
       "      <td>In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL646844</td>\n",
       "      <td>10.1016/s0960-894x(99)00118-3</td>\n",
       "      <td>10230628</td>\n",
       "      <td>CHEMBL1132082</td>\n",
       "      <td>Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21</td>\n",
       "      <td>C15H14F3NO2</td>\n",
       "      <td>CHEMBL6843</td>\n",
       "      <td>2.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.00</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>2.00</td>\n",
       "      <td>2.00</td>\n",
       "      <td>0.301030</td>\n",
       "      <td>0.301030</td>\n",
       "      <td>0.301030</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>717</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entry 0: BAO_0000188, Entry 1: BAO_0000188, Entry 2: BAO_0000188, Entry 3: BAO_0000188, Entry 4: BAO_0000188, Entry 5: BAO_0000188, Entry 6: BAO_0000188, Entry 7: BAO_0000188, Entry 8: BAO_0000188, Entry 9: BAO_0000188, Entry 10: BAO_0000188, Entry 11: BAO_0000188, Entry 12: BAO_0000188,</td>\n",
       "      <td>EC50</td>\n",
       "      <td>Entry 0: 35937, Entry 1: 467614, Entry 2: 805652, Entry 3: 805653, Entry 4: 796602, Entry 5: 796603, Entry 6: 796604, Entry 7: 944548, Entry 8: 944549, Entry 9: 964272, Entry 10: 964273, Entry 11: 1473767, Entry 12: 1473768,</td>\n",
       "      <td>Entry 0: In vitro antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cells, Entry 1: Agonist activity at human androgen receptor african green monkey CV1 cells by cotransfection assay, Entry 2: Agonist activity at androgen receptor expressed in Cos7 cells after 24 hrs ...</td>\n",
       "      <td>Entry 0: F, Entry 1: F, Entry 2: F, Entry 3: F, Entry 4: F, Entry 5: F, Entry 6: F, Entry 7: B, Entry 8: B, Entry 9: B, Entry 10: B, Entry 11: B, Entry 12: B,</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entry 0: CHEMBL646845, Entry 1: CHEMBL930489, Entry 2: CHEMBL1960486, Entry 3: CHEMBL1960487, Entry 4: CHEMBL1937917, Entry 5: CHEMBL1937918, Entry 6: CHEMBL1937919, Entry 7: CHEMBL2339064, Entry 8: CHEMBL2339065, Entry 9: CHEMBL2395386, Entry 10: CHEMBL2395387, Entry 11: CHEMBL3418492, Entry 12...</td>\n",
       "      <td>Entry 0: 10.1016/s0960-894x(99)00118-3, Entry 1: 10.1016/j.bmcl.2008.03.085, Entry 2: 10.1016/j.bmc.2012.02.005, Entry 3: 10.1016/j.bmc.2012.02.005, Entry 4: 10.1016/j.bmc.2011.10.067, Entry 5: 10.1016/j.bmc.2011.10.067, Entry 6: 10.1016/j.bmc.2011.10.067, Entry 7: 10.1016/j.bmc.2012.11.001, Ent...</td>\n",
       "      <td>Entry 0: 10230628, Entry 1: 18442912, Entry 2: 22391033, Entry 3: 22391033, Entry 4: 22094279, Entry 5: 22094279, Entry 6: 22094279, Entry 7: 23199477, Entry 8: 23199477, Entry 9: 23713567, Entry 10: 23713567, Entry 11: 25591066, Entry 12: 25591066,</td>\n",
       "      <td>Entry 0: CHEMBL1132082, Entry 1: CHEMBL1143080, Entry 2: CHEMBL1955860, Entry 3: CHEMBL1955860, Entry 4: CHEMBL1932924, Entry 5: CHEMBL1932924, Entry 6: CHEMBL1932924, Entry 7: CHEMBL2331321, Entry 8: CHEMBL2331321, Entry 9: CHEMBL2390857, Entry 10: CHEMBL2390857, Entry 11: CHEMBL3414506, Entry ...</td>\n",
       "      <td>Entry 0: Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one., Entry 1: Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones., Entry 2: Design, synthesis, and biological evaluation of 4-arylmethyl-1-ph...</td>\n",
       "      <td>Entry 0: PUBLICATION, Entry 1: PUBLICATION, Entry 2: PUBLICATION, Entry 3: PUBLICATION, Entry 4: PUBLICATION, Entry 5: PUBLICATION, Entry 6: PUBLICATION, Entry 7: PUBLICATION, Entry 8: PUBLICATION, Entry 9: PUBLICATION, Entry 10: PUBLICATION, Entry 11: PUBLICATION, Entry 12: PUBLICATION,</td>\n",
       "      <td>Entry 0: A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1</td>\n",
       "      <td>C18H14F4N2O4S</td>\n",
       "      <td>CHEMBL409</td>\n",
       "      <td>31.00</td>\n",
       "      <td>157.0</td>\n",
       "      <td>180.0</td>\n",
       "      <td>971.0</td>\n",
       "      <td>1400.0</td>\n",
       "      <td>4300.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>10000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4514.181167</td>\n",
       "      <td>31.00</td>\n",
       "      <td>5926.076923</td>\n",
       "      <td>10000.00</td>\n",
       "      <td>10000.00</td>\n",
       "      <td>3.772767</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>1.491362</td>\n",
       "      <td>5.227233</td>\n",
       "      <td>5.000000</td>\n",
       "      <td>7.508638</td>\n",
       "      <td>13</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>790</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>35936</td>\n",
       "      <td>In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL646844</td>\n",
       "      <td>10.1016/s0960-894x(99)00118-3</td>\n",
       "      <td>10230628</td>\n",
       "      <td>CHEMBL1132082</td>\n",
       "      <td>Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCC1CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1</td>\n",
       "      <td>C15H14F3NO2</td>\n",
       "      <td>CHEMBL266473</td>\n",
       "      <td>7.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>7.00</td>\n",
       "      <td>7.000000</td>\n",
       "      <td>7.00</td>\n",
       "      <td>7.00</td>\n",
       "      <td>0.845098</td>\n",
       "      <td>0.845098</td>\n",
       "      <td>0.845098</td>\n",
       "      <td>8.154902</td>\n",
       "      <td>8.154902</td>\n",
       "      <td>8.154902</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>791</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>35936</td>\n",
       "      <td>In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL646844</td>\n",
       "      <td>10.1016/s0960-894x(99)00118-3</td>\n",
       "      <td>10230628</td>\n",
       "      <td>CHEMBL1132082</td>\n",
       "      <td>Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC1(C)CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1</td>\n",
       "      <td>C15H14F3NO2</td>\n",
       "      <td>CHEMBL7289</td>\n",
       "      <td>9.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>9.00</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>9.00</td>\n",
       "      <td>9.00</td>\n",
       "      <td>0.954243</td>\n",
       "      <td>0.954243</td>\n",
       "      <td>0.954243</td>\n",
       "      <td>8.045757</td>\n",
       "      <td>8.045757</td>\n",
       "      <td>8.045757</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>2768533</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>2214670</td>\n",
       "      <td>Modulation of Androgen receptor (unknown origin)</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL5127802</td>\n",
       "      <td>10.1016/j.ejmech.2022.114119</td>\n",
       "      <td>35063736</td>\n",
       "      <td>CHEMBL5126525</td>\n",
       "      <td>Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21</td>\n",
       "      <td>C19H28O2</td>\n",
       "      <td>CHEMBL5197302</td>\n",
       "      <td>9.20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>9.20</td>\n",
       "      <td>9.200000</td>\n",
       "      <td>9.20</td>\n",
       "      <td>9.20</td>\n",
       "      <td>0.963788</td>\n",
       "      <td>0.963788</td>\n",
       "      <td>0.963788</td>\n",
       "      <td>8.036212</td>\n",
       "      <td>8.036212</td>\n",
       "      <td>8.036212</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>2775077</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>2214690</td>\n",
       "      <td>Agonist activity at Androgen receptor (unknown origin)</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL5127822</td>\n",
       "      <td>10.1016/j.ejmech.2022.114119</td>\n",
       "      <td>35063736</td>\n",
       "      <td>CHEMBL5126525</td>\n",
       "      <td>Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>O=C1COc2c(Cl)cc(Cl)cc2C(C(=O)Nc2ccc(C(F)(F)F)cc2)N1</td>\n",
       "      <td>C17H11Cl2F3N2O3</td>\n",
       "      <td>CHEMBL5203846</td>\n",
       "      <td>25.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>25.00</td>\n",
       "      <td>25.000000</td>\n",
       "      <td>25.00</td>\n",
       "      <td>25.00</td>\n",
       "      <td>1.397940</td>\n",
       "      <td>1.397940</td>\n",
       "      <td>1.397940</td>\n",
       "      <td>7.602060</td>\n",
       "      <td>7.602060</td>\n",
       "      <td>7.602060</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>2775481</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>2214670</td>\n",
       "      <td>Modulation of Androgen receptor (unknown origin)</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL5127802</td>\n",
       "      <td>10.1016/j.ejmech.2022.114119</td>\n",
       "      <td>35063736</td>\n",
       "      <td>CHEMBL5126525</td>\n",
       "      <td>Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H]([C@@H](C)C[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C</td>\n",
       "      <td>C29H46O3</td>\n",
       "      <td>CHEMBL5204250</td>\n",
       "      <td>1000.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1000.00</td>\n",
       "      <td>1000.000000</td>\n",
       "      <td>1000.00</td>\n",
       "      <td>1000.00</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>1</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>INACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>2778925</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>2214690</td>\n",
       "      <td>Agonist activity at Androgen receptor (unknown origin)</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL5127822</td>\n",
       "      <td>10.1016/j.ejmech.2022.114119</td>\n",
       "      <td>35063736</td>\n",
       "      <td>CHEMBL5126525</td>\n",
       "      <td>Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cc1cc(Cl)cc2c1OCC(=O)NC2C(=O)Nc1ccc([N+](=O)[O-])cc1</td>\n",
       "      <td>C17H14ClN3O5</td>\n",
       "      <td>CHEMBL5207694</td>\n",
       "      <td>10.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>10.00</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>10.00</td>\n",
       "      <td>10.00</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>2780436</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>2227403</td>\n",
       "      <td>Agonist activity at Androgen receptor (unknown origin) measured by androgen response element luciferase assay</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL5140916</td>\n",
       "      <td>10.1021/acs.jmedchem.2c00716</td>\n",
       "      <td>35786895</td>\n",
       "      <td>CHEMBL5137058</td>\n",
       "      <td>Therapeutic Strategies to Target the Androgen Receptor.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>The androgen receptor (AR) plays a key role in the maintenance of muscle and bone and the support of male sexual-related functions, as well as in the progression of prostate cancer. Accordingly, AR-targeted therapies have been developed for the treatment of related human diseases and conditions....</td>\n",
       "      <td>NaN</td>\n",
       "      <td>C[C@](O)(CCOc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21</td>\n",
       "      <td>C20H19FN2O3</td>\n",
       "      <td>CHEMBL5209205</td>\n",
       "      <td>2.50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.50</td>\n",
       "      <td>2.500000</td>\n",
       "      <td>2.50</td>\n",
       "      <td>2.50</td>\n",
       "      <td>0.397940</td>\n",
       "      <td>0.397940</td>\n",
       "      <td>0.397940</td>\n",
       "      <td>8.602060</td>\n",
       "      <td>8.602060</td>\n",
       "      <td>8.602060</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>664 rows × 79 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     comp_molregno act_standard_units act_standard_type  act_activity_comment  \\\n",
       "0              173                 nM              EC50                   NaN   \n",
       "1              716                 nM              EC50                   NaN   \n",
       "2              717                 nM              EC50                   NaN   \n",
       "3              790                 nM              EC50                   NaN   \n",
       "4              791                 nM              EC50                   NaN   \n",
       "..             ...                ...               ...                   ...   \n",
       "659        2768533                 nM              EC50                   NaN   \n",
       "660        2775077                 nM              EC50                   NaN   \n",
       "661        2775481                 nM              EC50                   NaN   \n",
       "662        2778925                 nM              EC50                   NaN   \n",
       "663        2780436                 nM              EC50                   NaN   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                      act_bao_endpoint  \\\n",
       "0                                                                                                                                                                                                                                                                                          BAO_0000188   \n",
       "1                                                                                                                                                                                                                                                                                          BAO_0000188   \n",
       "2    Entry 0: BAO_0000188, Entry 1: BAO_0000188, Entry 2: BAO_0000188, Entry 3: BAO_0000188, Entry 4: BAO_0000188, Entry 5: BAO_0000188, Entry 6: BAO_0000188, Entry 7: BAO_0000188, Entry 8: BAO_0000188, Entry 9: BAO_0000188, Entry 10: BAO_0000188, Entry 11: BAO_0000188, Entry 12: BAO_0000188,    \n",
       "3                                                                                                                                                                                                                                                                                          BAO_0000188   \n",
       "4                                                                                                                                                                                                                                                                                          BAO_0000188   \n",
       "..                                                                                                                                                                                                                                                                                                 ...   \n",
       "659                                                                                                                                                                                                                                                                                        BAO_0000188   \n",
       "660                                                                                                                                                                                                                                                                                        BAO_0000188   \n",
       "661                                                                                                                                                                                                                                                                                        BAO_0000188   \n",
       "662                                                                                                                                                                                                                                                                                        BAO_0000188   \n",
       "663                                                                                                                                                                                                                                                                                        BAO_0000188   \n",
       "\n",
       "    act_type  \\\n",
       "0       EC50   \n",
       "1       EC50   \n",
       "2       EC50   \n",
       "3       EC50   \n",
       "4       EC50   \n",
       "..       ...   \n",
       "659     EC50   \n",
       "660     EC50   \n",
       "661     EC50   \n",
       "662     EC50   \n",
       "663     EC50   \n",
       "\n",
       "                                                                                                                                                                                                                          ass_assay_id  \\\n",
       "0                                                                                                                                                                                                                               941808   \n",
       "1                                                                                                                                                                                                                                35936   \n",
       "2    Entry 0: 35937, Entry 1: 467614, Entry 2: 805652, Entry 3: 805653, Entry 4: 796602, Entry 5: 796603, Entry 6: 796604, Entry 7: 944548, Entry 8: 944549, Entry 9: 964272, Entry 10: 964273, Entry 11: 1473767, Entry 12: 1473768,    \n",
       "3                                                                                                                                                                                                                                35936   \n",
       "4                                                                                                                                                                                                                                35936   \n",
       "..                                                                                                                                                                                                                                 ...   \n",
       "659                                                                                                                                                                                                                            2214670   \n",
       "660                                                                                                                                                                                                                            2214690   \n",
       "661                                                                                                                                                                                                                            2214670   \n",
       "662                                                                                                                                                                                                                            2214690   \n",
       "663                                                                                                                                                                                                                            2227403   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                 ass_description  \\\n",
       "0                                                                                         Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay   \n",
       "1                                                                                                                                                                                                          In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.   \n",
       "2    Entry 0: In vitro antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cells, Entry 1: Agonist activity at human androgen receptor african green monkey CV1 cells by cotransfection assay, Entry 2: Agonist activity at androgen receptor expressed in Cos7 cells after 24 hrs ...   \n",
       "3                                                                                                                                                                                                          In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.   \n",
       "4                                                                                                                                                                                                          In vitro agonistic activity against human androgen receptor using cotransfection assay in CV-1 cells.   \n",
       "..                                                                                                                                                                                                                                                                                                           ...   \n",
       "659                                                                                                                                                                                                                                                             Modulation of Androgen receptor (unknown origin)   \n",
       "660                                                                                                                                                                                                                                                       Agonist activity at Androgen receptor (unknown origin)   \n",
       "661                                                                                                                                                                                                                                                             Modulation of Androgen receptor (unknown origin)   \n",
       "662                                                                                                                                                                                                                                                       Agonist activity at Androgen receptor (unknown origin)   \n",
       "663                                                                                                                                                                                                Agonist activity at Androgen receptor (unknown origin) measured by androgen response element luciferase assay   \n",
       "\n",
       "                                                                                                                                                      ass_assay_type  \\\n",
       "0                                                                                                                                                                  B   \n",
       "1                                                                                                                                                                  F   \n",
       "2    Entry 0: F, Entry 1: F, Entry 2: F, Entry 3: F, Entry 4: F, Entry 5: F, Entry 6: F, Entry 7: B, Entry 8: B, Entry 9: B, Entry 10: B, Entry 11: B, Entry 12: B,    \n",
       "3                                                                                                                                                                  F   \n",
       "4                                                                                                                                                                  F   \n",
       "..                                                                                                                                                               ...   \n",
       "659                                                                                                                                                                B   \n",
       "660                                                                                                                                                                B   \n",
       "661                                                                                                                                                                B   \n",
       "662                                                                                                                                                                B   \n",
       "663                                                                                                                                                                B   \n",
       "\n",
       "     ass_assay_category  \\\n",
       "0                   NaN   \n",
       "1                   NaN   \n",
       "2                   NaN   \n",
       "3                   NaN   \n",
       "4                   NaN   \n",
       "..                  ...   \n",
       "659                 NaN   \n",
       "660                 NaN   \n",
       "661                 NaN   \n",
       "662                 NaN   \n",
       "663                 NaN   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                   ass_chembl_id  \\\n",
       "0                                                                                                                                                                                                                                                                                                  CHEMBL2329799   \n",
       "1                                                                                                                                                                                                                                                                                                   CHEMBL646844   \n",
       "2    Entry 0: CHEMBL646845, Entry 1: CHEMBL930489, Entry 2: CHEMBL1960486, Entry 3: CHEMBL1960487, Entry 4: CHEMBL1937917, Entry 5: CHEMBL1937918, Entry 6: CHEMBL1937919, Entry 7: CHEMBL2339064, Entry 8: CHEMBL2339065, Entry 9: CHEMBL2395386, Entry 10: CHEMBL2395387, Entry 11: CHEMBL3418492, Entry 12...   \n",
       "3                                                                                                                                                                                                                                                                                                   CHEMBL646844   \n",
       "4                                                                                                                                                                                                                                                                                                   CHEMBL646844   \n",
       "..                                                                                                                                                                                                                                                                                                           ...   \n",
       "659                                                                                                                                                                                                                                                                                                CHEMBL5127802   \n",
       "660                                                                                                                                                                                                                                                                                                CHEMBL5127822   \n",
       "661                                                                                                                                                                                                                                                                                                CHEMBL5127802   \n",
       "662                                                                                                                                                                                                                                                                                                CHEMBL5127822   \n",
       "663                                                                                                                                                                                                                                                                                                CHEMBL5140916   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                         doc_doi  \\\n",
       "0                                                                                                                                                                                                                                                                                              10.1021/jm3017656   \n",
       "1                                                                                                                                                                                                                                                                                  10.1016/s0960-894x(99)00118-3   \n",
       "2    Entry 0: 10.1016/s0960-894x(99)00118-3, Entry 1: 10.1016/j.bmcl.2008.03.085, Entry 2: 10.1016/j.bmc.2012.02.005, Entry 3: 10.1016/j.bmc.2012.02.005, Entry 4: 10.1016/j.bmc.2011.10.067, Entry 5: 10.1016/j.bmc.2011.10.067, Entry 6: 10.1016/j.bmc.2011.10.067, Entry 7: 10.1016/j.bmc.2012.11.001, Ent...   \n",
       "3                                                                                                                                                                                                                                                                                  10.1016/s0960-894x(99)00118-3   \n",
       "4                                                                                                                                                                                                                                                                                  10.1016/s0960-894x(99)00118-3   \n",
       "..                                                                                                                                                                                                                                                                                                           ...   \n",
       "659                                                                                                                                                                                                                                                                                 10.1016/j.ejmech.2022.114119   \n",
       "660                                                                                                                                                                                                                                                                                 10.1016/j.ejmech.2022.114119   \n",
       "661                                                                                                                                                                                                                                                                                 10.1016/j.ejmech.2022.114119   \n",
       "662                                                                                                                                                                                                                                                                                 10.1016/j.ejmech.2022.114119   \n",
       "663                                                                                                                                                                                                                                                                                 10.1021/acs.jmedchem.2c00716   \n",
       "\n",
       "                                                                                                                                                                                                                                                  doc_pubmed_id  \\\n",
       "0                                                                                                                                                                                                                                                      23432095   \n",
       "1                                                                                                                                                                                                                                                      10230628   \n",
       "2    Entry 0: 10230628, Entry 1: 18442912, Entry 2: 22391033, Entry 3: 22391033, Entry 4: 22094279, Entry 5: 22094279, Entry 6: 22094279, Entry 7: 23199477, Entry 8: 23199477, Entry 9: 23713567, Entry 10: 23713567, Entry 11: 25591066, Entry 12: 25591066,    \n",
       "3                                                                                                                                                                                                                                                      10230628   \n",
       "4                                                                                                                                                                                                                                                      10230628   \n",
       "..                                                                                                                                                                                                                                                          ...   \n",
       "659                                                                                                                                                                                                                                                    35063736   \n",
       "660                                                                                                                                                                                                                                                    35063736   \n",
       "661                                                                                                                                                                                                                                                    35063736   \n",
       "662                                                                                                                                                                                                                                                    35063736   \n",
       "663                                                                                                                                                                                                                                                    35786895   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                   doc_chembl_id  \\\n",
       "0                                                                                                                                                                                                                                                                                                  CHEMBL2321830   \n",
       "1                                                                                                                                                                                                                                                                                                  CHEMBL1132082   \n",
       "2    Entry 0: CHEMBL1132082, Entry 1: CHEMBL1143080, Entry 2: CHEMBL1955860, Entry 3: CHEMBL1955860, Entry 4: CHEMBL1932924, Entry 5: CHEMBL1932924, Entry 6: CHEMBL1932924, Entry 7: CHEMBL2331321, Entry 8: CHEMBL2331321, Entry 9: CHEMBL2390857, Entry 10: CHEMBL2390857, Entry 11: CHEMBL3414506, Entry ...   \n",
       "3                                                                                                                                                                                                                                                                                                  CHEMBL1132082   \n",
       "4                                                                                                                                                                                                                                                                                                  CHEMBL1132082   \n",
       "..                                                                                                                                                                                                                                                                                                           ...   \n",
       "659                                                                                                                                                                                                                                                                                                CHEMBL5126525   \n",
       "660                                                                                                                                                                                                                                                                                                CHEMBL5126525   \n",
       "661                                                                                                                                                                                                                                                                                                CHEMBL5126525   \n",
       "662                                                                                                                                                                                                                                                                                                CHEMBL5126525   \n",
       "663                                                                                                                                                                                                                                                                                                CHEMBL5137058   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                       doc_title  \\\n",
       "0                                                                                                              Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.   \n",
       "1                                                                                                                                                                                                           Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.   \n",
       "2    Entry 0: Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one., Entry 1: Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones., Entry 2: Design, synthesis, and biological evaluation of 4-arylmethyl-1-ph...   \n",
       "3                                                                                                                                                                                                           Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.   \n",
       "4                                                                                                                                                                                                           Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.   \n",
       "..                                                                                                                                                                                                                                                                                                           ...   \n",
       "659                                                                                                                                                                     Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).   \n",
       "660                                                                                                                                                                     Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).   \n",
       "661                                                                                                                                                                     Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).   \n",
       "662                                                                                                                                                                     Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).   \n",
       "663                                                                                                                                                                                                                                                      Therapeutic Strategies to Target the Androgen Receptor.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                          doc_doc_type  \\\n",
       "0                                                                                                                                                                                                                                                                                          PUBLICATION   \n",
       "1                                                                                                                                                                                                                                                                                          PUBLICATION   \n",
       "2    Entry 0: PUBLICATION, Entry 1: PUBLICATION, Entry 2: PUBLICATION, Entry 3: PUBLICATION, Entry 4: PUBLICATION, Entry 5: PUBLICATION, Entry 6: PUBLICATION, Entry 7: PUBLICATION, Entry 8: PUBLICATION, Entry 9: PUBLICATION, Entry 10: PUBLICATION, Entry 11: PUBLICATION, Entry 12: PUBLICATION,    \n",
       "3                                                                                                                                                                                                                                                                                          PUBLICATION   \n",
       "4                                                                                                                                                                                                                                                                                          PUBLICATION   \n",
       "..                                                                                                                                                                                                                                                                                                 ...   \n",
       "659                                                                                                                                                                                                                                                                                        PUBLICATION   \n",
       "660                                                                                                                                                                                                                                                                                        PUBLICATION   \n",
       "661                                                                                                                                                                                                                                                                                        PUBLICATION   \n",
       "662                                                                                                                                                                                                                                                                                        PUBLICATION   \n",
       "663                                                                                                                                                                                                                                                                                        PUBLICATION   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                    doc_abstract  \\\n",
       "0    Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...   \n",
       "1    A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...   \n",
       "2    Entry 0: A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substi...   \n",
       "3    A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...   \n",
       "4    A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted ana...   \n",
       "..                                                                                                                                                                                                                                                                                                           ...   \n",
       "659  Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...   \n",
       "660  Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...   \n",
       "661  Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...   \n",
       "662  Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial or weak androgen receptor (AR) agonists in androgenic ti...   \n",
       "663  The androgen receptor (AR) plays a key role in the maintenance of muscle and bone and the support of male sexual-related functions, as well as in the progression of prostate cancer. Accordingly, AR-targeted therapies have been developed for the treatment of related human diseases and conditions....   \n",
       "\n",
       "     doc_patent_id  \\\n",
       "0              NaN   \n",
       "1              NaN   \n",
       "2              NaN   \n",
       "3              NaN   \n",
       "4              NaN   \n",
       "..             ...   \n",
       "659            NaN   \n",
       "660            NaN   \n",
       "661            NaN   \n",
       "662            NaN   \n",
       "663            NaN   \n",
       "\n",
       "                                                                   coms_canonical_smiles  \\\n",
       "0                                         COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1   \n",
       "1                                                   CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21   \n",
       "2                              CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1   \n",
       "3                                                   CCC1CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1   \n",
       "4                                                 CC1(C)CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1   \n",
       "..                                                                                   ...   \n",
       "659                 C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21   \n",
       "660                                  O=C1COc2c(Cl)cc(Cl)cc2C(C(=O)Nc2ccc(C(F)(F)F)cc2)N1   \n",
       "661  CCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H]([C@@H](C)C[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C   \n",
       "662                                 Cc1cc(Cl)cc2c1OCC(=O)NC2C(=O)Nc1ccc([N+](=O)[O-])cc1   \n",
       "663                                      C[C@](O)(CCOc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21   \n",
       "\n",
       "    comp_full_molformula mold_chembl_id    act_0  act_1  act_2  act_3   act_4  \\\n",
       "0            C19H16ClNO4        CHEMBL6     0.14    NaN    NaN    NaN     NaN   \n",
       "1            C15H14F3NO2     CHEMBL6843     2.00    NaN    NaN    NaN     NaN   \n",
       "2          C18H14F4N2O4S      CHEMBL409    31.00  157.0  180.0  971.0  1400.0   \n",
       "3            C15H14F3NO2   CHEMBL266473     7.00    NaN    NaN    NaN     NaN   \n",
       "4            C15H14F3NO2     CHEMBL7289     9.00    NaN    NaN    NaN     NaN   \n",
       "..                   ...            ...      ...    ...    ...    ...     ...   \n",
       "659             C19H28O2  CHEMBL5197302     9.20    NaN    NaN    NaN     NaN   \n",
       "660      C17H11Cl2F3N2O3  CHEMBL5203846    25.00    NaN    NaN    NaN     NaN   \n",
       "661             C29H46O3  CHEMBL5204250  1000.00    NaN    NaN    NaN     NaN   \n",
       "662         C17H14ClN3O5  CHEMBL5207694    10.00    NaN    NaN    NaN     NaN   \n",
       "663          C20H19FN2O3  CHEMBL5209205     2.50    NaN    NaN    NaN     NaN   \n",
       "\n",
       "      act_5    act_6    act_7    act_8    act_9   act_10   act_11   act_12  \\\n",
       "0       NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "1       NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "2    4300.0  10000.0  10000.0  10000.0  10000.0  10000.0  10000.0  10000.0   \n",
       "3       NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "4       NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "..      ...      ...      ...      ...      ...      ...      ...      ...   \n",
       "659     NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "660     NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "661     NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "662     NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "663     NaN      NaN      NaN      NaN      NaN      NaN      NaN      NaN   \n",
       "\n",
       "     act_13  act_14  act_15  act_16  act_17  act_18  act_19  act_20  act_21  \\\n",
       "0       NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "1       NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "2       NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "3       NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "4       NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "..      ...     ...     ...     ...     ...     ...     ...     ...     ...   \n",
       "659     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "660     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "661     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "662     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "663     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "     act_22  act_23  act_24  act_25      act_std  act_min     act_mean  \\\n",
       "0       NaN     NaN     NaN     NaN     0.000000     0.14     0.140000   \n",
       "1       NaN     NaN     NaN     NaN     0.000000     2.00     2.000000   \n",
       "2       NaN     NaN     NaN     NaN  4514.181167    31.00  5926.076923   \n",
       "3       NaN     NaN     NaN     NaN     0.000000     7.00     7.000000   \n",
       "4       NaN     NaN     NaN     NaN     0.000000     9.00     9.000000   \n",
       "..      ...     ...     ...     ...          ...      ...          ...   \n",
       "659     NaN     NaN     NaN     NaN     0.000000     9.20     9.200000   \n",
       "660     NaN     NaN     NaN     NaN     0.000000    25.00    25.000000   \n",
       "661     NaN     NaN     NaN     NaN     0.000000  1000.00  1000.000000   \n",
       "662     NaN     NaN     NaN     NaN     0.000000    10.00    10.000000   \n",
       "663     NaN     NaN     NaN     NaN     0.000000     2.50     2.500000   \n",
       "\n",
       "     act_median   act_max  log_act_mean  log_act_median  log_act_min  \\\n",
       "0          0.14      0.14     -0.853872       -0.853872    -0.853872   \n",
       "1          2.00      2.00      0.301030        0.301030     0.301030   \n",
       "2      10000.00  10000.00      3.772767        4.000000     1.491362   \n",
       "3          7.00      7.00      0.845098        0.845098     0.845098   \n",
       "4          9.00      9.00      0.954243        0.954243     0.954243   \n",
       "..          ...       ...           ...             ...          ...   \n",
       "659        9.20      9.20      0.963788        0.963788     0.963788   \n",
       "660       25.00     25.00      1.397940        1.397940     1.397940   \n",
       "661     1000.00   1000.00      3.000000        3.000000     3.000000   \n",
       "662       10.00     10.00      1.000000        1.000000     1.000000   \n",
       "663        2.50      2.50      0.397940        0.397940     0.397940   \n",
       "\n",
       "     pEC50_mean  pEC50_median  pEC50_min  meas_count class_activity_mean_1000  \\\n",
       "0      9.853872      9.853872   9.853872           1                   ACTIVE   \n",
       "1      8.698970      8.698970   8.698970           1                   ACTIVE   \n",
       "2      5.227233      5.000000   7.508638          13                 INACTIVE   \n",
       "3      8.154902      8.154902   8.154902           1                   ACTIVE   \n",
       "4      8.045757      8.045757   8.045757           1                   ACTIVE   \n",
       "..          ...           ...        ...         ...                      ...   \n",
       "659    8.036212      8.036212   8.036212           1                   ACTIVE   \n",
       "660    7.602060      7.602060   7.602060           1                   ACTIVE   \n",
       "661    6.000000      6.000000   6.000000           1                 INACTIVE   \n",
       "662    8.000000      8.000000   8.000000           1                   ACTIVE   \n",
       "663    8.602060      8.602060   8.602060           1                   ACTIVE   \n",
       "\n",
       "    class_activity_median_1000 class_activity_min_1000  \\\n",
       "0                       ACTIVE                  ACTIVE   \n",
       "1                       ACTIVE                  ACTIVE   \n",
       "2                     INACTIVE                  ACTIVE   \n",
       "3                       ACTIVE                  ACTIVE   \n",
       "4                       ACTIVE                  ACTIVE   \n",
       "..                         ...                     ...   \n",
       "659                     ACTIVE                  ACTIVE   \n",
       "660                     ACTIVE                  ACTIVE   \n",
       "661                   INACTIVE                INACTIVE   \n",
       "662                     ACTIVE                  ACTIVE   \n",
       "663                     ACTIVE                  ACTIVE   \n",
       "\n",
       "    class_activity_max_1000 class_activity_mean_2000  \\\n",
       "0                    ACTIVE                   ACTIVE   \n",
       "1                    ACTIVE                   ACTIVE   \n",
       "2                  INACTIVE                 INACTIVE   \n",
       "3                    ACTIVE                   ACTIVE   \n",
       "4                    ACTIVE                   ACTIVE   \n",
       "..                      ...                      ...   \n",
       "659                  ACTIVE                   ACTIVE   \n",
       "660                  ACTIVE                   ACTIVE   \n",
       "661                INACTIVE                   ACTIVE   \n",
       "662                  ACTIVE                   ACTIVE   \n",
       "663                  ACTIVE                   ACTIVE   \n",
       "\n",
       "    class_activity_median_2000 class_activity_min_2000  \\\n",
       "0                       ACTIVE                  ACTIVE   \n",
       "1                       ACTIVE                  ACTIVE   \n",
       "2                     INACTIVE                  ACTIVE   \n",
       "3                       ACTIVE                  ACTIVE   \n",
       "4                       ACTIVE                  ACTIVE   \n",
       "..                         ...                     ...   \n",
       "659                     ACTIVE                  ACTIVE   \n",
       "660                     ACTIVE                  ACTIVE   \n",
       "661                     ACTIVE                  ACTIVE   \n",
       "662                     ACTIVE                  ACTIVE   \n",
       "663                     ACTIVE                  ACTIVE   \n",
       "\n",
       "    class_activity_max_2000 class_activity_mean_3000  \\\n",
       "0                    ACTIVE                   ACTIVE   \n",
       "1                    ACTIVE                   ACTIVE   \n",
       "2                  INACTIVE                 INACTIVE   \n",
       "3                    ACTIVE                   ACTIVE   \n",
       "4                    ACTIVE                   ACTIVE   \n",
       "..                      ...                      ...   \n",
       "659                  ACTIVE                   ACTIVE   \n",
       "660                  ACTIVE                   ACTIVE   \n",
       "661                  ACTIVE                   ACTIVE   \n",
       "662                  ACTIVE                   ACTIVE   \n",
       "663                  ACTIVE                   ACTIVE   \n",
       "\n",
       "    class_activity_median_3000 class_activity_min_3000  \\\n",
       "0                       ACTIVE                  ACTIVE   \n",
       "1                       ACTIVE                  ACTIVE   \n",
       "2                     INACTIVE                  ACTIVE   \n",
       "3                       ACTIVE                  ACTIVE   \n",
       "4                       ACTIVE                  ACTIVE   \n",
       "..                         ...                     ...   \n",
       "659                     ACTIVE                  ACTIVE   \n",
       "660                     ACTIVE                  ACTIVE   \n",
       "661                     ACTIVE                  ACTIVE   \n",
       "662                     ACTIVE                  ACTIVE   \n",
       "663                     ACTIVE                  ACTIVE   \n",
       "\n",
       "    class_activity_max_3000 class_activity_mean_4000  \\\n",
       "0                    ACTIVE                   ACTIVE   \n",
       "1                    ACTIVE                   ACTIVE   \n",
       "2                  INACTIVE                 INACTIVE   \n",
       "3                    ACTIVE                   ACTIVE   \n",
       "4                    ACTIVE                   ACTIVE   \n",
       "..                      ...                      ...   \n",
       "659                  ACTIVE                   ACTIVE   \n",
       "660                  ACTIVE                   ACTIVE   \n",
       "661                  ACTIVE                   ACTIVE   \n",
       "662                  ACTIVE                   ACTIVE   \n",
       "663                  ACTIVE                   ACTIVE   \n",
       "\n",
       "    class_activity_median_4000 class_activity_min_4000  \\\n",
       "0                       ACTIVE                  ACTIVE   \n",
       "1                       ACTIVE                  ACTIVE   \n",
       "2                     INACTIVE                  ACTIVE   \n",
       "3                       ACTIVE                  ACTIVE   \n",
       "4                       ACTIVE                  ACTIVE   \n",
       "..                         ...                     ...   \n",
       "659                     ACTIVE                  ACTIVE   \n",
       "660                     ACTIVE                  ACTIVE   \n",
       "661                     ACTIVE                  ACTIVE   \n",
       "662                     ACTIVE                  ACTIVE   \n",
       "663                     ACTIVE                  ACTIVE   \n",
       "\n",
       "    class_activity_max_4000 class_activity_mean_5000  \\\n",
       "0                    ACTIVE                   ACTIVE   \n",
       "1                    ACTIVE                   ACTIVE   \n",
       "2                  INACTIVE                 INACTIVE   \n",
       "3                    ACTIVE                   ACTIVE   \n",
       "4                    ACTIVE                   ACTIVE   \n",
       "..                      ...                      ...   \n",
       "659                  ACTIVE                   ACTIVE   \n",
       "660                  ACTIVE                   ACTIVE   \n",
       "661                  ACTIVE                   ACTIVE   \n",
       "662                  ACTIVE                   ACTIVE   \n",
       "663                  ACTIVE                   ACTIVE   \n",
       "\n",
       "    class_activity_median_5000 class_activity_min_5000 class_activity_max_5000  \n",
       "0                       ACTIVE                  ACTIVE                  ACTIVE  \n",
       "1                       ACTIVE                  ACTIVE                  ACTIVE  \n",
       "2                     INACTIVE                  ACTIVE                INACTIVE  \n",
       "3                       ACTIVE                  ACTIVE                  ACTIVE  \n",
       "4                       ACTIVE                  ACTIVE                  ACTIVE  \n",
       "..                         ...                     ...                     ...  \n",
       "659                     ACTIVE                  ACTIVE                  ACTIVE  \n",
       "660                     ACTIVE                  ACTIVE                  ACTIVE  \n",
       "661                     ACTIVE                  ACTIVE                  ACTIVE  \n",
       "662                     ACTIVE                  ACTIVE                  ACTIVE  \n",
       "663                     ACTIVE                  ACTIVE                  ACTIVE  \n",
       "\n",
       "[664 rows x 79 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['comp_molregno', 'act_standard_units', 'act_standard_type',\n",
       "       'act_activity_comment', 'act_bao_endpoint', 'act_type', 'ass_assay_id',\n",
       "       'ass_description', 'ass_assay_type', 'ass_assay_category',\n",
       "       'ass_chembl_id', 'doc_doi', 'doc_pubmed_id', 'doc_chembl_id',\n",
       "       'doc_title', 'doc_doc_type', 'doc_abstract', 'doc_patent_id',\n",
       "       'coms_canonical_smiles', 'comp_full_molformula', 'mold_chembl_id',\n",
       "       'act_0', 'act_1', 'act_2', 'act_3', 'act_4', 'act_5', 'act_6', 'act_7',\n",
       "       'act_8', 'act_9', 'act_10', 'act_11', 'act_12', 'act_13', 'act_14',\n",
       "       'act_15', 'act_16', 'act_17', 'act_18', 'act_19', 'act_20', 'act_21',\n",
       "       'act_22', 'act_23', 'act_24', 'act_25', 'act_std', 'act_min',\n",
       "       'act_mean', 'act_median', 'act_max', 'log_act_mean', 'log_act_median',\n",
       "       'log_act_min', 'pEC50_mean', 'pEC50_median', 'pEC50_min', 'meas_count',\n",
       "       'class_activity_mean_1000', 'class_activity_median_1000',\n",
       "       'class_activity_min_1000', 'class_activity_max_1000',\n",
       "       'class_activity_mean_2000', 'class_activity_median_2000',\n",
       "       'class_activity_min_2000', 'class_activity_max_2000',\n",
       "       'class_activity_mean_3000', 'class_activity_median_3000',\n",
       "       'class_activity_min_3000', 'class_activity_max_3000',\n",
       "       'class_activity_mean_4000', 'class_activity_median_4000',\n",
       "       'class_activity_min_4000', 'class_activity_max_4000',\n",
       "       'class_activity_mean_5000', 'class_activity_median_5000',\n",
       "       'class_activity_min_5000', 'class_activity_max_5000'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>comp_molregno</th>\n",
       "      <th>act_standard_units</th>\n",
       "      <th>act_standard_type</th>\n",
       "      <th>act_activity_comment</th>\n",
       "      <th>act_bao_endpoint</th>\n",
       "      <th>act_type</th>\n",
       "      <th>ass_assay_id</th>\n",
       "      <th>ass_description</th>\n",
       "      <th>ass_assay_type</th>\n",
       "      <th>ass_assay_category</th>\n",
       "      <th>ass_chembl_id</th>\n",
       "      <th>doc_doi</th>\n",
       "      <th>doc_pubmed_id</th>\n",
       "      <th>doc_chembl_id</th>\n",
       "      <th>doc_title</th>\n",
       "      <th>doc_doc_type</th>\n",
       "      <th>doc_abstract</th>\n",
       "      <th>doc_patent_id</th>\n",
       "      <th>coms_canonical_smiles</th>\n",
       "      <th>comp_full_molformula</th>\n",
       "      <th>mold_chembl_id</th>\n",
       "      <th>act_0</th>\n",
       "      <th>act_1</th>\n",
       "      <th>act_2</th>\n",
       "      <th>act_3</th>\n",
       "      <th>act_4</th>\n",
       "      <th>act_5</th>\n",
       "      <th>act_6</th>\n",
       "      <th>act_7</th>\n",
       "      <th>act_8</th>\n",
       "      <th>act_9</th>\n",
       "      <th>act_10</th>\n",
       "      <th>act_11</th>\n",
       "      <th>act_12</th>\n",
       "      <th>act_13</th>\n",
       "      <th>act_14</th>\n",
       "      <th>act_15</th>\n",
       "      <th>act_16</th>\n",
       "      <th>act_17</th>\n",
       "      <th>act_18</th>\n",
       "      <th>act_19</th>\n",
       "      <th>act_20</th>\n",
       "      <th>act_21</th>\n",
       "      <th>act_22</th>\n",
       "      <th>act_23</th>\n",
       "      <th>act_24</th>\n",
       "      <th>act_25</th>\n",
       "      <th>act_std</th>\n",
       "      <th>act_min</th>\n",
       "      <th>act_mean</th>\n",
       "      <th>act_median</th>\n",
       "      <th>act_max</th>\n",
       "      <th>log_act_mean</th>\n",
       "      <th>log_act_median</th>\n",
       "      <th>log_act_min</th>\n",
       "      <th>pEC50_mean</th>\n",
       "      <th>pEC50_median</th>\n",
       "      <th>pEC50_min</th>\n",
       "      <th>meas_count</th>\n",
       "      <th>class_activity_mean_1000</th>\n",
       "      <th>class_activity_median_1000</th>\n",
       "      <th>class_activity_min_1000</th>\n",
       "      <th>class_activity_max_1000</th>\n",
       "      <th>class_activity_mean_2000</th>\n",
       "      <th>class_activity_median_2000</th>\n",
       "      <th>class_activity_min_2000</th>\n",
       "      <th>class_activity_max_2000</th>\n",
       "      <th>class_activity_mean_3000</th>\n",
       "      <th>class_activity_median_3000</th>\n",
       "      <th>class_activity_min_3000</th>\n",
       "      <th>class_activity_max_3000</th>\n",
       "      <th>class_activity_mean_4000</th>\n",
       "      <th>class_activity_median_4000</th>\n",
       "      <th>class_activity_min_4000</th>\n",
       "      <th>class_activity_max_4000</th>\n",
       "      <th>class_activity_mean_5000</th>\n",
       "      <th>class_activity_median_5000</th>\n",
       "      <th>class_activity_min_5000</th>\n",
       "      <th>class_activity_max_5000</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [comp_molregno, act_standard_units, act_standard_type, act_activity_comment, act_bao_endpoint, act_type, ass_assay_id, ass_description, ass_assay_type, ass_assay_category, ass_chembl_id, doc_doi, doc_pubmed_id, doc_chembl_id, doc_title, doc_doc_type, doc_abstract, doc_patent_id, coms_canonical_smiles, comp_full_molformula, mold_chembl_id, act_0, act_1, act_2, act_3, act_4, act_5, act_6, act_7, act_8, act_9, act_10, act_11, act_12, act_13, act_14, act_15, act_16, act_17, act_18, act_19, act_20, act_21, act_22, act_23, act_24, act_25, act_std, act_min, act_mean, act_median, act_max, log_act_mean, log_act_median, log_act_min, pEC50_mean, pEC50_median, pEC50_min, meas_count, class_activity_mean_1000, class_activity_median_1000, class_activity_min_1000, class_activity_max_1000, class_activity_mean_2000, class_activity_median_2000, class_activity_min_2000, class_activity_max_2000, class_activity_mean_3000, class_activity_median_3000, class_activity_min_3000, class_activity_max_3000, class_activity_mean_4000, class_activity_median_4000, class_activity_min_4000, class_activity_max_4000, class_activity_mean_5000, class_activity_median_5000, class_activity_min_5000, class_activity_max_5000]\n",
       "Index: []"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[(df[\"doc_doc_type\"]==\"DATASET\") & (df[\"ass_chembl_id\"]==\"CHEMBL2114928\")]#[\"ass_chembl_id\"].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>comp_molregno</th>\n",
       "      <th>act_standard_units</th>\n",
       "      <th>act_standard_type</th>\n",
       "      <th>act_activity_comment</th>\n",
       "      <th>act_bao_endpoint</th>\n",
       "      <th>act_type</th>\n",
       "      <th>ass_assay_id</th>\n",
       "      <th>ass_description</th>\n",
       "      <th>ass_assay_type</th>\n",
       "      <th>ass_assay_category</th>\n",
       "      <th>ass_chembl_id</th>\n",
       "      <th>doc_doi</th>\n",
       "      <th>doc_pubmed_id</th>\n",
       "      <th>doc_chembl_id</th>\n",
       "      <th>doc_title</th>\n",
       "      <th>doc_doc_type</th>\n",
       "      <th>doc_abstract</th>\n",
       "      <th>doc_patent_id</th>\n",
       "      <th>coms_canonical_smiles</th>\n",
       "      <th>comp_full_molformula</th>\n",
       "      <th>mold_chembl_id</th>\n",
       "      <th>act_0</th>\n",
       "      <th>act_1</th>\n",
       "      <th>act_2</th>\n",
       "      <th>act_3</th>\n",
       "      <th>act_4</th>\n",
       "      <th>act_5</th>\n",
       "      <th>act_6</th>\n",
       "      <th>act_7</th>\n",
       "      <th>act_8</th>\n",
       "      <th>act_9</th>\n",
       "      <th>act_10</th>\n",
       "      <th>act_11</th>\n",
       "      <th>act_12</th>\n",
       "      <th>act_13</th>\n",
       "      <th>act_14</th>\n",
       "      <th>act_15</th>\n",
       "      <th>act_16</th>\n",
       "      <th>act_17</th>\n",
       "      <th>act_18</th>\n",
       "      <th>act_19</th>\n",
       "      <th>act_20</th>\n",
       "      <th>act_21</th>\n",
       "      <th>act_22</th>\n",
       "      <th>act_23</th>\n",
       "      <th>act_24</th>\n",
       "      <th>act_25</th>\n",
       "      <th>act_std</th>\n",
       "      <th>act_min</th>\n",
       "      <th>act_mean</th>\n",
       "      <th>act_median</th>\n",
       "      <th>act_max</th>\n",
       "      <th>log_act_mean</th>\n",
       "      <th>log_act_median</th>\n",
       "      <th>log_act_min</th>\n",
       "      <th>pEC50_mean</th>\n",
       "      <th>pEC50_median</th>\n",
       "      <th>pEC50_min</th>\n",
       "      <th>meas_count</th>\n",
       "      <th>class_activity_mean_1000</th>\n",
       "      <th>class_activity_median_1000</th>\n",
       "      <th>class_activity_min_1000</th>\n",
       "      <th>class_activity_max_1000</th>\n",
       "      <th>class_activity_mean_2000</th>\n",
       "      <th>class_activity_median_2000</th>\n",
       "      <th>class_activity_min_2000</th>\n",
       "      <th>class_activity_max_2000</th>\n",
       "      <th>class_activity_mean_3000</th>\n",
       "      <th>class_activity_median_3000</th>\n",
       "      <th>class_activity_min_3000</th>\n",
       "      <th>class_activity_max_3000</th>\n",
       "      <th>class_activity_mean_4000</th>\n",
       "      <th>class_activity_median_4000</th>\n",
       "      <th>class_activity_min_4000</th>\n",
       "      <th>class_activity_max_4000</th>\n",
       "      <th>class_activity_mean_5000</th>\n",
       "      <th>class_activity_median_5000</th>\n",
       "      <th>class_activity_min_5000</th>\n",
       "      <th>class_activity_max_5000</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>173</td>\n",
       "      <td>nM</td>\n",
       "      <td>EC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BAO_0000188</td>\n",
       "      <td>EC50</td>\n",
       "      <td>941808</td>\n",
       "      <td>Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay</td>\n",
       "      <td>B</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL2329799</td>\n",
       "      <td>10.1021/jm3017656</td>\n",
       "      <td>23432095</td>\n",
       "      <td>CHEMBL2321830</td>\n",
       "      <td>Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.</td>\n",
       "      <td>PUBLICATION</td>\n",
       "      <td>Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1</td>\n",
       "      <td>C19H16ClNO4</td>\n",
       "      <td>CHEMBL6</td>\n",
       "      <td>0.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.14</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>-0.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>9.853872</td>\n",
       "      <td>1</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "      <td>ACTIVE</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   comp_molregno act_standard_units act_standard_type  act_activity_comment  \\\n",
       "0            173                 nM              EC50                   NaN   \n",
       "\n",
       "  act_bao_endpoint act_type ass_assay_id  \\\n",
       "0      BAO_0000188     EC50       941808   \n",
       "\n",
       "                                                                                                                                                                                                          ass_description  \\\n",
       "0  Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay   \n",
       "\n",
       "  ass_assay_type  ass_assay_category  ass_chembl_id            doc_doi  \\\n",
       "0              B                 NaN  CHEMBL2329799  10.1021/jm3017656   \n",
       "\n",
       "  doc_pubmed_id  doc_chembl_id  \\\n",
       "0      23432095  CHEMBL2321830   \n",
       "\n",
       "                                                                                                                                                                                           doc_title  \\\n",
       "0  Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.   \n",
       "\n",
       "  doc_doc_type  \\\n",
       "0  PUBLICATION   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                  doc_abstract  \\\n",
       "0  Castrate-resistant prostate cancer (CRPC) is a fatal, metastatic form of prostate cancer. CRPC is characterized by reactivation of the androgen axis due to changes in androgen receptor signaling and/or adaptive intratumoral androgen biosynthesis. AKR1C3 is upregulated in CRPC where it catalyzes ...   \n",
       "\n",
       "   doc_patent_id                           coms_canonical_smiles  \\\n",
       "0            NaN  COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1   \n",
       "\n",
       "  comp_full_molformula mold_chembl_id  act_0  act_1  act_2  act_3  act_4  \\\n",
       "0          C19H16ClNO4        CHEMBL6   0.14    NaN    NaN    NaN    NaN   \n",
       "\n",
       "   act_5  act_6  act_7  act_8  act_9  act_10  act_11  act_12  act_13  act_14  \\\n",
       "0    NaN    NaN    NaN    NaN    NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "   act_15  act_16  act_17  act_18  act_19  act_20  act_21  act_22  act_23  \\\n",
       "0     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN     NaN   \n",
       "\n",
       "   act_24  act_25  act_std  act_min  act_mean  act_median  act_max  \\\n",
       "0     NaN     NaN      0.0     0.14      0.14        0.14     0.14   \n",
       "\n",
       "   log_act_mean  log_act_median  log_act_min  pEC50_mean  pEC50_median  \\\n",
       "0     -0.853872       -0.853872    -0.853872    9.853872      9.853872   \n",
       "\n",
       "   pEC50_min  meas_count class_activity_mean_1000 class_activity_median_1000  \\\n",
       "0   9.853872           1                   ACTIVE                     ACTIVE   \n",
       "\n",
       "  class_activity_min_1000 class_activity_max_1000 class_activity_mean_2000  \\\n",
       "0                  ACTIVE                  ACTIVE                   ACTIVE   \n",
       "\n",
       "  class_activity_median_2000 class_activity_min_2000 class_activity_max_2000  \\\n",
       "0                     ACTIVE                  ACTIVE                  ACTIVE   \n",
       "\n",
       "  class_activity_mean_3000 class_activity_median_3000 class_activity_min_3000  \\\n",
       "0                   ACTIVE                     ACTIVE                  ACTIVE   \n",
       "\n",
       "  class_activity_max_3000 class_activity_mean_4000 class_activity_median_4000  \\\n",
       "0                  ACTIVE                   ACTIVE                     ACTIVE   \n",
       "\n",
       "  class_activity_min_4000 class_activity_max_4000 class_activity_mean_5000  \\\n",
       "0                  ACTIVE                  ACTIVE                   ACTIVE   \n",
       "\n",
       "  class_activity_median_5000 class_activity_min_5000 class_activity_max_5000  \n",
       "0                     ACTIVE                  ACTIVE                  ACTIVE  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: >"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df[\"class_activity_median_1000\"].hist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(DATA_DIR/\"processed\"/\"ar_homo_sapiens_chembl_3.3_more_ChEMBL_columnsEC50.csv_processed.csv\", sep=\",\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "WindowsPath('../data')"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "DATA_DIR"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "datacuration",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.16"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "ac4ec8b5bb2a6a3e72cfad53cce750f339367d72bd548343afd00f2bde87e267"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
